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1. Summary 
Neurons are highly polarized cells that constantly undergo remodeling of their branches 
during and after their development. This energy demanding process depends on energy 
provision from mitochondria via the oxidative phosphorylation (OXPHOS). Although the 
molecular mechanisms connecting the two are important for understanding pathologies linked 
to defective neuronal branching due to mitochondrial deficiency, they still remain elusive. In 
this study, we approached this problem by using as a model a highly branched sensory neuron 
in Caenorhabditis elegans which demonstrates altered branching pattern in conditions of 
mitochondrial deficiency. In particular, we show that animals carrying mutations in genes 
encoding mitochondrial complex I subunits have more dendrites on their sensory neurons 
compared to wild type animals. The increased outgrowth is not a cell type-specific 
phenomenon since other types of sensory neurons demonstrate ectopic structures due to 
complex I deficiency, as well. Importantly, the increased branching is not a result of oxidative 
stress, but it is regulated by a distinct signaling cascade. Specifically, activation of AMP-
activated protein kinase AMPK due to mitochondrial deficiency is one of the regulatory 
events and we show that its downstream target phosphoinositide 3-kinase PI3K participates in 
the same pathway. Finally, we demonstrated that the increased neuronal arborizations 
displayed by OXPHOS mutants are independent of their longevity. Overall, our findings 
reveal a signaling pathway which regulates tightly dendritic branching in conditions of 
mitochondrial deficiency and contribute to the understanding of more complicated 
phenomena occurring in relevant neurodegenerative diseases. 
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2. Introduction  
8 
 
2.1 Neuronal morphology and neurodegeneration 
Ever since Santiago Ramón y Cajal, the founder of neuroscience, described the organization 
of the neurons and the vertebrate nervous system in the late 1800s, the scientific community is 
aware of the complicated shape of these cells and their intense polarization [1]. Indeed the 
neurons display a high degree of morphological and functional polarization. Neurons are 
characterized by the presence of neuronal projections or neurites which mostly include a long 
thin axon and shorter dendrites. Additionally, dendrites carry spines on their surface which are 
small outgrowths and receive synaptic input. This high polarization is essential for the 
determination of the direction of the signal flow in neurons [2]. Therefore, the formation and 
maintenance of a neuron’s projections are directly linked to its functionality. 
The process of forming and maintaining neuronal projections is firmly orchestrated and it 
requires a big variety of branching determinants and accompanying proteins as well as a 
significant amount of energy [3, 4]. In addition, neurons undergo morphological changes due 
to stimuli from their environment which includes other neurons [3, 4]. This leads to neuronal 
circuit formation and their maintenance as well as their plasticity are of pivotal importance for 
the proper function of the brain [5]. Taking the above under consideration, it is expected that 
compromised structural integrity of the neurons can lead to defective communication between 
the neurons of a circuit which can eventually affect the function of the entire brain and result 
into cognitive impairment. 
Alterations in neuronal morphology are associated with neurodegenerative diseases that can 
lead to cognitive impairment. Despite the fact that neurodegenerative diseases alter neurite 
and spine morphology, the mechanisms connecting neurodegenerative diseases and alterations 
in neuronal morphology as well as the causative relation between them are not well 
understood. Several neurodegenerative diseases like Alzheimer’s and Parkinson’s have been 
shown to implicate reorganization of dendritic structures. Briefly, Alzheimer’s disease is the 
most common form of dementia [6] and it is histologically characterized by the formation of 
amyloid plaques and neurofibrillary tangles. The main component of the plaques is the Aβ 
amyloid which is formed by small peptides of 40-42 amino acids called Aβ42 [7]. The 
neurofibrillary tangles consist of tau protein which aggregates into insoluble fibrillar deposits 
when it is hyperphoshorylated [8]. On the other hand, Parkinson’s disease causes loss of 
dopaminergic neurons in a specific brain area, namely the substantia nigra, and leads to 
diminishing of the control over voluntary movement [9]. Histologically, this disease is 
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characterized by neuronal inclusions, the Lewy bodies and the Lewy neurites [10]. Both types 
of inclusions contain a pre-synaptic protein, α-synuclein, in an aggregated, oligomeric or 
fibrillar form [11]. Both Alzheimer’s and Parkinson’s diseases result into reorganization of 
dendritic branching in basal forebrain neurons of patients [12]. Additionally, it has been also 
proposed that degenerating neurites represent a cause rather than a consequence of Aβ 
accumulation in late-onset Alzheimer’s [13]. 
Another example of a neurodegenerative disease that leads to neuronal loss and remodeling is 
Huntington’s disease. Huntington’s disease is inherited in an autosomal dominant manner and 
it occurs due to expansion of a CAG trinucleotide repeat in the huntingtin (HTT) gene which 
results into an expanded polyglutamine stretch in the HTT protein. The disease is 
histologically characterized by loss of specific neuronal subpopulations in the cortex and 
striatum [14] and clinically by chorea, cognitive impairment and psychiatric disorders [15]. 
Regarding the neurite remodeling associated with Huntington’s disease, striatal neurons from 
patients were found to have both degenerative and proliferative changes such as increased 
numbers and size of dendritic spines, short-segment branching along dendrites and truncated 
dendritic arborizations [16, 17].  
Although the neurodegenerative diseases discussed above as well as others occur with high 
frequencies [18], the mechanisms underlying the involved neurite degeneration remain 
obscure. Therefore, there is an urgent need for understanding these mechanisms. 
 
2.2 Role of mitochondria in neurodegeneration 
Neurons need to form and maintain a specific shape in order to be functional and able to 
communicate with the neurons of the circuits they belong to. A great variety of factors is 
responsible for the shaping of the neurons. In many different ways, mitochondria have also 
been implicated in this process and as consequence, in neurodegeneration [19]. 
Mitochondria produce energy through the oxidative phosphorylation. The oxidative 
phosphorylation is the metabolic pathway whose end product is ATP, the molecule that 
funnels energy into metabolism. Five main protein complexes (Complexes I-V) are involved 
in the energy production and they comprise an electron transport chain system. These 
complexes are embedded in the inner mitochondrial membrane and the electron transport 
generates a proton gradient which is exploited by ATP synthase (Complex V) that forms ATP 
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from ADP and inorganic phosphate in a phosphorylation reaction [20]. Among other cellular 
processes, neurons require energy to form and maintain their projections. Indeed, ATP level 
reduction has been shown to result in defective dendrite morphogenesis. For example, 
downregulation of the Cytoplasmic Polyadenylation Element Binding protein 1 (CPEB1) 
which is responsible for the transcription of an mRNA encoding one of the subunits of 
Complex I, causes reduction of the ATP production. This reduction led to reduced neurite 
formation of primary neurons from CPEB1 knockout mice compared to wild type animals 
[21]. 
Secondly, mitochondria are dynamic organelles undergoing circles of fusion and fission. 
Overall mitochondria form mostly tubular networks inside the cells and these networks can 
shift their shape in response to certain stimuli [22]. Fusion and fission are the two processes 
that sculpt the mitochondrial network and their physiological role has been linked to 
mitochondrial integrity maintenance, proliferation, as well as content exchange such as 
mitochondrial DNA [23]. It has been demonstrated that fusion and fission occurs in neurons 
as a means of distribution of mitochondria in neurites. This distribution occurs in response to 
neuronal activity and it is correlated with synaptogenesis, neurite and spine formation. Indeed, 
neurons that have defective fission mechanisms do not form small mitochondrial fragments 
that can be transferred to the thin neuronal projections and assist with the local needs of the 
projection. Mitochondria depleted projections  have fewer spines and synapses and these 
neurons form fewer neurites as shown by studies on hippocampal [24], cultured forebrain 
neurons [25] and Purkinje cells [26]. 
Apart from fusion and fission, mitochondria are distributed inside the cell via active 
transportation, (mitochondrial trafficking). Adaptor proteins and kinesins form complexes in 
order to achieve mitochondrial transportation via the microtubules to the loci where the 
energy demands require the presence of mitochondria [22, 27]. It has been demonstrated that 
immobilization of mitochondria can have an impact on neurite formation and specifically 
axon branching. In particular, it was shown both in vivo and in vitro that two kinases, LKB1 
and NUAK1 are necessary and sufficient to immobilize mitochondria at nascent presynaptic 
sites. This immobilization is of vital importance for the branching stimulation since mobile 
mitochondria are not able to induce branching [28]. 
Considering the effect the disruptions of the mitochondrial function can have on the 
morphology of neurons, it is only logical to hypothesize that mitochondrial deficiencies might 
be involved in neurodegenerative diseases. Indeed, mutations in mitochondrial DNA and 
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oxidative stress contribute to ageing which is the greatest risk factor for the onset of 
neurodegeneration and evidence suggests that mitochondrial dysfunction may occur early and 
act causally in neurodegenerative diseases [29]. Moreover, patients having mitochondrial 
deficiencies manifest a variety of symptoms most of which are of neurological nature [30], a 
fact which highlights even more the importance of intact mitochondria for proper neuronal 
function. 
Several studies have found that mitochondrial dysfunction and oxidative damage can 
contribute to the pathogenesis of Alzheimer’s disease [31, 32]. In addition, defective 
trafficking of organelles, including mitochondria was found in autoptic patients with sporadic 
Alzheimer’s [33]. Abnormal mitochondrial dynamics are present in Alzheimer’s disease 
models and are thought to contribute to the pathology [34]. Finally, evidence from a mouse 
model of Alzheimer’s disease confirmed the implication of decreased anterograde 
mitochondrial movement, increased mitochondrial fission and decreased fusion, defective 
mitochondrial function as well as impaired mitochondrial biogenesis in primary neurons of 
these mice [35]. 
Inhibition of the mitochondrial complex I has been found to be relevant in naturally occurring 
Parkinson’s disease since complex I deficiency was found in the substantia nigra of patients 
with either  idiopathic or pre-symptomatic Parkinson’s disease [36]. Moreover, although there 
are some discrepancies in the reported phenotypes, mitochondrial dynamics seem to be 
affected in different models of Parkinson’s disease or in tissues from patients [37].  
Disturbance of almost all of the mitochondrial functions has been involved in the 
pathophysiology of Huntington’s disease [38, 39]. Specifically, it is thought that the mutant 
huntingtin directly associates with mitochondria since it has been found that it can bind on the 
outer mitochondrial membrane [40] and interferes with certain mitochondrial functions such 
as protein import [41]. Examination of postmortem brain samples from Huntington’s patients 
revealed decreased activity of complexes II and III [42]. Moreover, as recently demonstrated, 
the mutant huntingtin interacts with a mediator of mitochondrial fission (Dynamin-related 
protein-Drp1) leading to excessive fragmentation of mitochondria and thus to neuronal 
damage [43].  
Although there is accumulating evidence regarding the correlation of mitochondrial 
dysfunction and neurodegenerative diseases, it is not yet clear in most of the cases if 
mitochondrial dysfunction is a causal or a consequential effect for each neurodegenerative 
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disease. In addition, little is known about the signaling pathways that mediate the 
neurodegeneration due to mitochondrial deficiencies.  
 
2.3 Caenorhabditis elegans as a model organism  
Caenorhabditis elegans is a free living (non-parasitic) nematode. The species belongs to the 
Phylum Nematoda, Class Chromadorea, Order Rhabditida, Family Rhabditidae and Genus 
Caenorhabditis (Maupas, É. “Modes et forms de reproduction des nématodes”, 1900). 
C. elegans was firstly introduced as a model organism in 1974 by Sydney Brenner. His work 
focused mostly on establishing the basic genetic features of the organism as well as on the 
development of methods for determining the structure of its nervous system [44]. Ever since, 
C. elegans has been extensively used as a model organism in the fields of ageing [45, 46], 
neurobiology [47, 48], developmental biology [49], immunology [50, 51], biomedicine [52, 
53] and others. The level of its characterization as a model is highlighted by the number of 
existing databases and tools that are available online. Some examples are the Wormatlas 
(http://www.wormatlas.org/) which is a database of behavioral and structural anatomy of C. 
elegans, the Wormbase (http://www.wormbase.org) which contains C. elegans gene 
information with links to all available data for the respective genes, available mutant strains 
etc and the Wormweb (http://wormweb.org/neuralnet) which provides all the  information 
about the mapping of the nervous system of the organism. 
The extensive use of this simple model stems from the fact that it gathers a series of features 
and advantages that makes it particular. First of all, C. elegans homologues have been 
identified for ~80% of human genes [54] a fact that makes it a model relevant for 
investigations on human pathophysiology [55]. Regarding its maintenance in the laboratory, 
C. elegans is inexpensive and easy to handle. Its small size (~1 mm) and inexpensive 
maintenance materials along with its self-fertilizing reproduction mode allow culturing of 
large numbers of nematodes and of several strains simultaneously. Additionally, its short life 
cycle (4 days at 20ºC for wild type animals- Image 1) and short life span (approximately 30 
days at 20ºC for wild type animals) make it ideal for ageing studies. Moreover, the 
availability of mutant strains and RNAi constructs make C. elegans attractive for epistasis 
analyses and studies that require genetic approaches. In addition, the two strategies widely 
used for transgenesis in C. elegans are efficient and fast and both deliver exogenous DNA in 
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the worm’s germline. This is done either by microinjecting DNA directly in the germline 
which leads to the generation of extrachromosomal arrays consisting of several copies of the 
transgene, or by conducting biolistic transformation (bombardment) which results into 
integration of the transgene in the genome in low copy numbers [56]. Last but not least, all the 
mutant or transgenic strains can be maintained for several years since young larvae can 
survive freezing and thawing. 
 
2.4 The nervous system of C. elegans 
The C. elegans nervous system, which will be the focusing point of this study, has been 
extensively studied ever since the introduction of the model. In his first studies Sydney 
Brenner reported numerous observations on the neuronal mapping and nervous system 
organization of the roundworm [44]. The most complex tissue of C. elegans is its nervous 
system, and in fact, it comprises about one third of the total somatic cells of the adult worm 
(302 out of 959 in the hermaphrodite and 381 out of 1031 in the male). Reconstructions of 
electron micrographs have provided a full structure and connectivity map; 20 neurons are 
located in the pharynx and the rest in various ganglia in the head, tail and along the ventral 
cord (Image 2). Almost all of the neurons are morphologically simple with few or no branches 
[57]. C. elegans has sensory, motor and interneurons [57] as well as some glial cells [58] that 
participate in the organization of the nervous system.   
 
 
Image 1: Schematic showing the life cycle 
of wild type C. elegans at 22ºC. The adult 
animal is capable of laying ~300 eggs 
which hatch and give stage 1 larvae (L1). 
After 4 molting steps and about 3 days, the 
L1s reach the adulthood, thus completing 
the life cycle of this nematode. 
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What makes the study of the worm nervous system so attractive is firstly the transparency of 
its body which allows imaging of the neurons and secondly, the display of certain behavioral 
modalities which can be monitored to assess neuronal functionality. In addition, the 
introduction of the concept of expressing under tissue- or cell-specific promoters LacZ 
initially and the green fluorescent protein (GFP) later, enabled the tagging of single or groups 
of neurons, thus providing more information regarding details of their structure and 
development [59, 60]. Moreover, many characteristics present in the roundworm nervous 
system are found in mammalian neurons as well.  
For example, the C. elegans nervous system displays morphological alterations due to ageing 
[61-63], it possesses mechanisms of neuronal regeneration [64] and mechanisms of neuronal 
pruning [65], processes which occur in mammalian neurons as well and are relevant for 
pathological conditions of the nervous system. Lastly, neurotransmitter receptors, 
neurotransmitter synthesis and release pathways are highly conserved between C. elegans and 
mammals [66]. These similarities make C. elegans a model organism attractive for 
neurobiology studies relevant to human neuropathology.  
As mentioned earlier, C. elegans also exerts certain behavioral patterns which can be utilized 
to assess neuronal functionality and reveal the neurons that participate in certain circuits. One 
noteworthy example is the “basal slow response” which describes the slow-down of 
locomotion that well fed animals display when they encounter a bacterial lawn. This behavior 
is mediated by dopaminergic neurons, thus failure to exert this specific behavior can be linked 
to defective function of these neurons [67]. Moreover, several other behavioral paradigms in 
C. elegans such as odortaxis, thermotaxis and male mating have enabled us to identify genes 
that alter them as well as the neural circuits underlying each behavior [68]. 
 
Image 2: Image of a live worm expressing GFP 
under a pan-neuronal promoter. The single asterisk 
indicates the tail and the double asterisk the head. 
The cephalic (or head) ganglia as well as several 
neurons in the rest of body are clearly shown in the 
image. The strain is the OH441: otIs45 [unc-
119::gfp]. The scale bar represents 25 µm. 
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In this study we focused mainly on the PVD neurons. The PVD neurons (PVDL and PVDR) 
are mechanosensory - nociception neurons [57, 69]. They are born post-embryonically and 
they mediate an avoidance response to harsh touch [59]. It has been shown that these neurons 
can have a proprioception function as well, since their ablation can affect the posture of the 
animal [70]. In the adult animal the PVDs are fully developed and they envelop almost the 
entire body of the nematode. 
 
 
 
 
 
 
 
 
Image 3: The PVD neurons display an elaborate dendritic branching pattern. a) The PVD 
neuron of a late L4 animal. The development of the neurons is already complete and apart 
from the very posterior area the entire body in enveloped by both PVD neurons. The insert 
shows a “menorah” which is the repetitive structural unit of the neuron. The scale bar 
represents 25 µm. b) Schematic of the structure of two neighboring menorahs where the 
degrees of the branches are indicated. 
 
They demonstrate an elaborate branching pattern that consists of a certain number (~40 per 
animal) of non-overlapping repetitive structures (Image 3a). These repetitive structures are 
called “menorahs” because of their resemblance with candelabra and they follow a specific 
pattern during their development. The stem of each menorah (2º branch) grows on a primary 
branch (1º branch) which stems directly from the cell body and runs throughout almost the 
entire body of the nematode. When the 2º branches reach a certain size, they turn 90º and 
continue to grow thus forming the 3º branches. Finally, on the 3º branch 4º processes grow 
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(Image 3b). Most of the menorahs stop their development at this point although occasionally 
5º or 6º branches may appear. 
The structural complexity of this neuron has been proved to be a valuable tool for assessing 
roles of variable proteins in dendritic branch formation. For example, study of its tiling 
properties has revealed that netrin (UNC-6) regulates this process and prevents the 
overlapping of neighboring (or sister) dendrites [71]. Furthermore, novel complexes of 
membrane adhesion molecules have been revealed through the study of the PVD neuron. 
Reportedly, DMA-1, a transmembrane protein, is expressed on the PVD neuron and by 
binding to a ligand complex (SAX-7/L1CAM), which is expressed in the surrounding 
hypodermal tissue, it mediates branching of the neuron [72, 73]. Finally, cell-specific 
expression profiling of the PVD has uncovered a big portion of molecules that mediate its 
branching [69]. Although a deeper investigation is required on the data of this profiling, the 
information collected to this point as well as the PVD neuron itself, provide a promising 
model for identification of evolutionarily conserved branching determinants. 
 
2.5 C. elegans as a model to study neurodegeneration 
As previously discussed, C. elegans has a very well-defined nervous system and along with 
its utilization as a genetic model, it offers an effective platform to elucidate basic mechanistic 
pathways that underlie complex human neurodegenerative diseases. In fact, C. elegans has 
been extensively used to model and study neurodegeneration [74-76]. 
Alzheimer’s disease has been modeled and studied in C. elegans. Although C. elegans does 
not have tau and it does not generate Aβ peptides, heterologous expression of the human 
proteins is possible. Indeed, transgenic worms that express Aβ42 in pan-neuronal manner 
human have defective odorant preferences, associative learning behavior, experience-
dependent learning as well as egg laying [77]. Apart from heterologous expression systems, 
C. elegans can facilitate studying of Alzheimer’s in a homologous manner since it carries the 
apl-1 gene which encodes for the APL-1 (amyloid precursor-like protein) and it is the 
homolog of the APP human protein. In pathological conditions APP is cleaved by certain 
proteases and Aβ is produced which forms the plaques and leads to the disease onset. The C. 
elegans APL-1 lacks the protease cleaving site therefore Aβ cannot be produced [78]. 
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Nevertheless, a role for APL-1 in the nervous system of C. elegans has been found, 
specifically in regulating transmission at the body wall neuromuscular junction [79]. 
Similarly to Alzheimer’s disease, C. elegans lacks the orthologues of genes related to 
Parkinson’s disease such as α-synuclein. Nevertheless, some work has been done to model 
and study Parkinson’s in the worm through transgenic expression of human genes. Indeed, 
animals overexpressing human α-synuclein in dopaminergic neurons display loss of these 
neurons and defects the “basal slowing response” (see above) [80]. Alpha-synuclein is not the 
only culprit in Parkinson’s disease. Another gene commonly found to be mutated in familial 
Parkinson’s disease is the one encoding for the leucine-rich repeat kinase 2 (LRRK2) [81]. 
Overexpression of the human LRRK2 in selective neurons of C. elegans leads to degeneration 
of dopaminergic neurons [82]. 
Finally, Huntington’s disease has been modeled in C. elegans. The first model was 
established by overexpressing a huntingtin fragment with a 150CAG-repeat in sensory 
neurons of the worm in which the cytoplasmic aggregates of the protein increased with age 
and the neurons finally died through apoptosis [83]. Moreover, driving of the expression of 57 
N-terminal residues of huntingtin in touch neurons resulted in touch sensitivity deficits of the 
worms [84]. 
The aforementioned models can give precious insights in the mechanisms underlying 
neurodegenerative diseases. The suitability of C. elegans for genetic screens gives great value 
to the “humanized” worm models for neurodegenerative diseases: new genes involved in 
these pathologies can be identified fast as well as their function [85]. Lastly, C. elegans 
mitochondrial mutants can be studied as a model of neurodegeneration as a result of 
mitochondrial deficiency as shown by the present and other studies [86]. 
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Aim of the study 
The aim of this study was to identify the mechanism or some of the molecular players 
connecting mitochondrial impairment to neuronal remodeling. The connection of these two is 
of high interest since neuronal remodeling occurs in neurodegenerative diseases where 
mitochondrial deficiencies have been shown to play an important role. Therefore, we wanted 
first to confirm that mitochondrial impairment in a simple model can interfere with the 
morphology of neuronal arborizations. We chose C. elegans due to its suitability for studies 
that include genetic approaches and its very well mapped nervous system. After confirming 
that the neuronal architecture of C. elegans is affected in animals having mitochondrial 
impairments due to genetic lesions, we aimed to identify the signaling pathway that regulates 
this phenomenon. 
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3. Materials & Methods  
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Note: All the solution recipes (Table 1), reagents (Table 2), plasticware/glassware (Table 5) 
and pieces of equipment (Table 6) mentioned in the methods below are listed in the respective 
tables at the end of this section. In addition, tables containing all the primer sequences (Table 
4) and all the C. elegans strains (Table 3) used in this study are included. 
 
3.1 Strain maintenance 
• 3.1.1 Plate preparation and nematode culture 
Reagents and equipment: Petri dishes (55 or 90 mm diameter), NGM, OP50 cultures, 
LB medium 
 
Method description: The NGM was prepared (see Buffers and Media Table) and 
autoclaved. While still in liquid form, it was poured into petri dishes of either 55 or 90 
mm diameter. In case the plates were going to be used for treatments (with Vitamin C 
or AICAR) the substances were added before the medium was poured into the petri 
dishes. The plates were left for 2 days in room temperature to dry and to detect 
possible contaminations. Then, the plates were stored at 4-8ºC for up to 1 month, 
unless they contained Vitamin C or AICAR in which case the plates were used within 
5 days after their preparation. Before its use, each plate was seeded with an OP50 
bacterial lawn. OP50 is an E. coli strain which has a uracil auxotrophy and its growth 
is limited on NGM plates, thus forming a thin lawn which allows easy detection of the 
nematodes.  
A glycerol stock of OP50 was kept at all times at -80ºC and a fresh streaking was 
prepared every 2 weeks on an LB-agar plate and kept at 4ºC. An OP50 culture was 
prepared by adding one colony from the streaking plate in 200 mL LB medium in a 
conical flask and left for 6-8 hours at 37ºC under vigorous shaking. Then, 200 µL or 1 
mL, for 55 mm and 90 mm plates respectively, were pipetted on each NGM plate and 
left to dry overnight at room temperature. The next day the plates had a dry and grown 
bacterial lawn ready for use. The rest of the bacterial culture was kept at 4ºC and 
refreshed every 3-4 days. 
Adult animals, larvae, thawed stocks or freshly bleached eggs (see below) were placed 
on the surface of NGM plates seeded with OP50 bacterial lawns. The animals were 
left to grow until the desired stage or population size was reached and they were used 
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for further experiments according to the respective needs. NGM plates containing 
starved populations were chunked, the chunks were placed on freshly seeded plates 
and the nematodes were left for 3-4 days to recover before starting new experiments. 
 
• 3.1.2 Bleaching 
Reagents and equipment: bleaching solution, M9 buffer, sterile distilled H2O, Bunsen 
burner, stereomicroscope. 
 
Method description: The bleaching is conducted in order to synchronize a nematode 
culture or to clean contaminations. The bleaching solution dissolves the bodies of the 
nematodes whereas if the exposure is short enough, the eggs are left unharmed. 
Therefore, the culture intended for bleaching needs to contain gravid adult animals. 
Briefly, the animals were washed with H2O and put into 1.5 mL eppendorf tubes. The 
animals were left to settle and were washed 3 times. 100 µL of the supernatant were 
left in the tube where 500 µL of bleaching solution were added. The tubes were 
vortexed for 4-5 minutes until the bodies of the adult nematodes were dissolved and 
not detectable under a stereomicroscope. Then the tubes were immediately centrifuged 
at 10,000 rpm for 1 minute and the excess bleaching solution was discarded and 
replaced by sterile M9 buffer close to a flame. This step was repeated 3 times and 
finally the egg pellet was resuspended in 100-200 µL of M9 buffer and distributed on 
freshly seeded NGM plates. 
 
• 3.1.3 Long term storage (freezing) 
Reagents and equipment: S buffer, freezing solution, 1.8 mL cryo tubes. 
 
Method description: C. elegans stocks can be prepared and stored at -80ºC or liquid 
nitrogen for several years. The nematodes that have the greatest possibility of 
recovering after freezing are of the L1 stage, if frozen when freshly starved. In this 
study, for every strain requiring a stock preparation we used 4-6 NGM 90 mm 
diameter plates that contained as many freshly starved L1 larvae as possible. The 
animals were washed with S buffer and put into a 15 mL falcon tube. The volume was 
adjusted at 7 mL, an equal volume of freezing solution was added, and the mixture 
was equally distributed in 8 1.8 mL cryo tubes. The tubes were stored at -80ºC. A 
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week later one of the vials was thawed and a successful freezing was confirmed if 
minimum 100 larvae survived one day after the thawing. 
 
3.2 Ageing experiments 
Reagents and equipment: 55mm diameter NGM plates freshly seeded with OP50, 
platinum wire pick, stereomicroscope. 
Method description: A synchronized C. elegans cohort can be followed throughout 
its lifespan by selecting individuals and separating them from their progeny. Briefly, 
bleached eggs were placed on freshly seeded NGM plates. After 3 days 30-40 
animals were selected and placed on 2-3 fresh NGM plates. These animals were 
separated from their progeny by transferring them every other day on new NGM 
plates. Censored animals (desiccated, with internal hatching or vulval protrusions) 
were excluded from this analysis. In this study we followed nematode cohorts for 10 
days after the eggs hatched and imaged their neurons at 4, 6 and 10 days after their 
hatching. 
 
3.3 Genotyping 
• 3.3.1 Cross 
Reagents and equipment: 55mm diameter NGM plates seeded with a drop (~20 µL) of 
OP50 (mating plates), normally seeded 55mm diameter NGM plates. 
 
Method description: The first step of a cross is the generation of males for one of the 
two participating strains. The males have a single X chromosome (XO) as compared 
to hermaphrodites that have two (XX). The generation of gametes lacking one X 
chromosome happens when the segregation of the two X chromosomes during meiosis 
is inhibited. In the laboratory, we mimic the conditions causing the lack of X 
chromosome segregation by exposing animals that are still developing their gonads to 
heat stress. For this reason, 3-4 L4 larvae from the selected strain were placed in 55 
mm diameter NGM plates and incubated at 32ºC for 4 hours. After the incubation, the 
plates were moved to normal temperature (20ºC) while waiting for the L4s to develop 
and give progeny. In this generation some males were expected to be found. When the 
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males were obtained they were expanded so that the crosses could start. To 
maintain/expand the male population, nematodes with a high ratio of 
males/hermaphrodites were kept in the plates so that the chance of heterosexual 
mating is high.  
In this study, when the males had reached a sufficient population, we placed 15-20 of 
them on a mating plate with 1 or 2 young adult hermaphrodites of the other strain of 
interest. The males were left with the hermaphrodites for 2 days and the progeny (F1) 
was picked with a platinum wire and singled out in separate NGM plates. The F1 
animals were left to lay eggs for 2 days and then each animal was separately lysed and 
genotyped in order to find which one/ones carried the mutation/mutations of interest. 
The progeny of these F1 animals (F2) would undergo the same selection process. This 
set of steps was repeated for a number of generations (usually 4-6) until the desired 
genotype was obtained. 
 
• 3.3.2 Polymerase chain reaction (PCR) and agarose gel electophoresis 
Reagents and equipment: Lysis buffer, proteinase K (100 mg/mL), Taq polymerase, 
Taq polymerase buffer, dNTPs, PCR tubes, TBE buffer, agarose, agarose gel 
electrophoresis chambers, thermocycler. 
 
Method description: Briefly, PCR is used to amplify a particular DNA sequence. It 
requires thermal cycling, which consists of repeated cycles of heating and cooling for 
DNA melting and enzymatic replication. Primers containing sequences 
complementary to the target region and a DNA polymerase are necessary for a 
selective and repeated amplification. As the PCR progresses, the generated DNA is 
itself used as a template for replication, thereby promoting an exponential 
amplification of the template.  
In our study, firstly the worm lysate that would be used as a DNA template was 
obtained. As mentioned above, this came from a single worm. One animal was placed 
with the help of platinum wire and a stereomicroscope in a 0.2 mL PCR tube which 
contained 10 µL lysis buffer and 0.2 µL proteinase K. The tubes were placed in a 
thermocycler and incubated following the sequence: 1 hour at 65ºC (lysis), 10 minutes 
at 95ºC (proteinase K inactivation) and paused at 4ºC. At this point the lysates could 
be stored at -20ºC or immediately used for a PCR reaction. 
24 
 
Usually, the design of the primers used in each reaction is based on the nature of the 
mutations the crossed strains carry. For example, if the mutation is a deletion, the 
primers are designed accordingly so that they anneal either in the deleted part or in the 
regions flanking the deletion. In the first case the PCR will yield a product for the wild 
type but not the mutated allele, whereas in the second case the product for the wild 
allele will be longer compared to the one of the mutated allele. For all the primer 
sequences, see the Table 4 at the end of this section. 
Each PCR reaction was set as follows: 
 2 µL worm lysate (DNA template) 
 0.3 µL forward primer (10µM) 
 0.3 µL reverse primer (10µM) 
 1.5 µL 10x Polymerase Taq buffer 
 1.5 µL dNTPs 2mM each 
 0.1 µL Taq Polymerase (5 U/µL) 
 9.3 µL H2O 
_______________________________ 
Total reaction volume: 15 µL 
 
According to the number of samples that needed to be examined for a specific allele, 
one master mix was prepared containing all the reagents required for a PCR reaction, 
apart from the template. This master mix was then distributed among the tubes 
containing the DNA templates. 
 
After the PCR reaction, the presence or size of the product needed to be assessed. For 
that purpose the reactions were loaded into agarose gels which were stained with 
ethidium bromide which intercalates into the major grooves of the DNA and 
fluoresces under UV light. The DNA products were separated by applying an electric 
field which makes the negatively charged molecules move according to their size. The 
PCR products could be detected with the help of a UV lamp and with a standard DNA 
ladder, their size was determined. In this study, since all of the PCR products were 
sized from 100 to 500 base pairs (see Table 4), the gels used were 1.5 % w/v and 
contained ethidium bromide at a final concentration 0.5 µg/mL. The gel 
electrophoresis was conducted at 120-140 mV and it lasted 30-40 minutes depending 
on the size of the gel. 
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3.4 Confocal microscopy 
Reagents and equipment: mounting medium, microscope glass slides, coverslips, platinum 
wire pick, stereomicroscope and confocal microscope. 
Method description: Properly staged nematodes were left to crawl on bacteria-free surface of 
an NGM plate for 5 minutes in order to remove the bacteria from their bodies. 10-15 animals 
were then picked with a platinum wire and left in a 15 µL drop of mounting medium on a 
glass slide. The mounted animals were gently covered with a 24x24 mm coverslip which was 
sealed with nail polish. The preparation was immediately taken for imaging and a new one 
was prepared every 20 minutes until the desired number of animals was imaged. The imaging 
was conducted using an inverted Zeiss LSM700 confocal microscope equipped with several 
objective lenses. For this study an oil-immersion 40x objective lens was used. The imaging 
conditions included the use of a 488 nm laser at 1-2% of its power capacity, a pinhole of 70 
µm and the image resolution was 1024x1024 to maximize precision during analysis of the 
images. 
 
3.5 Western Blotting 
• 3.5.1 Protein extraction   
Reagents and equipment: RIPA buffer supplemented with PhosSTOP (1 tablet/10 mL) 
and Protease Inhibitor Cocktail (1/2 tablet/10 mL), sterile distilled H2O, ultrasonic 
disintegrator. 
 
Method description: The animals intended for western blotting were synchronized and 
collected on day 4. The animals were collected by washing the NGM plates with 
sterile distilled water and put into 1.5 mL eppendorf tubes. The nematodes were 
allowed to settle and washed 3 times in order to remove any remaining bacteria. After 
removing the supernatant of the last wash, the nematodes were resuspended in RIPA 
buffer supplemented as noted above. The amount of the added RIPA buffer varied 
from 80 to 150 µL according to the number of collected nematodes. The samples were 
kept on ice and sonicated with an ultrasonic disintegrator at medium amplitude for 10-
15 seconds until no unsolved particles could be detected in the tube. The samples were 
then centrifuged at 14.000 rpm for 20 minutes at 4ºC. Finally, the supernatant was 
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transferred into a clean tube. The samples at this stage could be either quantified for 
their protein content (see below) or stored at -20ºC until further use. 
 
 
• 3.5.2 Protein concentration determination (Bradford assay) and sample 
preparation 
Reagents and equipment: Bio-Rad Protein Assay Dye Reagent Concentrate diluted 
1:5, Albumin fraction V dissolved in H2O at 1 mg/mL (BSA), laemmli buffer 4x, 
sterile distilled water, cuvettes, spectrophotometer. 
 
Method description:  The principle of the Bradford assay is based on the fact that an 
acidic solution of the dye Coomassie Brilliant Blue G-250 can shift its absorbance 
maximum from 465 nm to 595 nm when bound to protein.  Thus, measuring the 
absorbance of protein samples diluted in the dye at 595 nm gives a number 
proportional to the protein concentration of each sample.  
In this study, for each Bradford assay a standard curve was generated in order to 
define the relation of the absorbance and the protein concentration of standard samples 
before measuring the ones intended for gel electrophoresis. For that purpose a BSA 
solution of known concentration was used. For each sample and standard we used 
duplicates to overcome pipetting errors. For the standards, 2 to 16 µL of BSA were 
pipetted in eppendorf tubes, whereas for the protein samples we used 2 µL. 1 mL of 
the diluted dye was added in each tube and they were inverted several times for 
mixing. The tubes were incubated for 5 minutes at room temperature. Before starting 
the measurement the spectrophotometer was adjusted at 595 nm and blanked with a 
sample containing only dye. Then, starting from the standard samples, we measured 
the absorbance of each one at a spectrophotometer at 595 nm after transferring each 
sample into appropriate cuvettes. The absorbance of the standards versus their 
concentration was plotted and the resulting equation was used to calculate the 
concentration of every sample.   
After calculating the concentration of each sample, they were aliquoted as follows: x 
µL of protein sample which contained 20 µg of protein and x/3 µl laemmli 4x. If the 
volume difference between the aliquots was greater than 5 µL, 1x laemmli was added 
to bring all the samples to the same volume. The samples were then boiled at 95ºC for 
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5 minutes. At this point the samples could either be stored at -20ºC or used for SDS 
polyacrylamide gel electrophoresis immediately. 
 
 
• 3.5.3 SDS polyacrylamide gel electrophoresis (SDS-PAGE) and gel transfer 
Reagents and equipment: Upper buffer, lower buffer, APS, TEMED, running buffer, 
acrylamide, transfer buffer, nitrocellulose, filter paper, sterile distilled H2O, protein 
marker, gel and transfer chambers. 
 
Method description: Polyacrylamide gel electrophoresis (PAGE) is a technique used to 
separate macromolecules according to their electrophoretic mobility. In this study 
SDS-PAGE was used for protein separation and the protein samples were treated with 
SDS in order to render them a negative charge. Therefore, the different proteins, when 
mobilized under an electrical field, get separated in the gel according to their size. 
Each gel consisted of two separately prepared gels; the stacking and the resolving gel. 
The purpose of the stacking gel is the concentration of the samples into tight bands 
before they enter the resolving gel. This is achieved through the almost neutral pH of 
the resolving gel (pH6.8) in which the Cl- ions (from the Tris-HCl) and the neutrally 
charged form of glycine can migrate in certain manner forming a narrow zone of two 
migrating fronts. When this migrating zone passes through the sample well the 
proteins are concentrated into a narrow band between the two fronts of migrating ions. 
When the ion front reaches the resolving gel, due to its alkaline pH (pH8.8) the 
glycine gets negatively charged and migrates faster compared to the proteins. The 
proteins enter a gel with a higher acrylamide percentage, ergo smaller pores, and they 
can start moving and separating according to their size.   
Briefly, the resolving gel was prepared in a 50 mL falcon tube (recipe below) and 
immediately poured between two glassplates assembled on a gel holder according to 
the manufacturer’s instructions. Approximately 2 cm from the top were left free for 
the stacking gel to be poured once the resolving gel was solid. The resolving gel was 
overlaid immediately after pouring with 1-2 mL of isopropanol to insure a flat surface. 
After 15-20 minutes, when the resolving gel had solidified, the stacking gel was 
prepared and similarly poured on top of the stacking gel after removing the 
isopropanol remains. A 10 well comb was immediately placed and left until the 
stacking gel was solid, to form the loading wells.  
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Resolving gel 12%: 
 20% v/v 30% acrylamide 
 25% v/v Lower buffer 
 1% v/v 10% APS 
 0.1% v/v TEMED 
_______________________________ 
For each gel of 1.5 mm of thickness, 10 mL of resolving gel were prepared. 
 
Stacking gel 6%: 
 40% v/v 30% acrylamide 
 25% v/v Upper buffer 
 1% v/v 10% APS 
 0.1% v/v TEMED 
_______________________________ 
For each gel of 1.5 mm of thickness, 4 mL of stacking gel were prepared. 
 
After 15-20 minutes, the combs were removed and the gels were placed inside an 
electrophoresis chamber according to the manufacturer’s instructions. The chamber 
was filled with 1x Running buffer as well as the loading wells. The protein aliquots 
prepared in earlier steps were loaded in the wells. One well out of ten was always used 
for a protein marker. The gels were left to run at 120 V for approximately 1.5 hours. 
After that, the proteins in the gel were ready to get transferred. 
The proteins were transferred from the gel to a nitrocellulose membrane, which served 
as a solid substrate, through tank blotting. In this case, the gel and the nitrocellulose 
membrane were stably assembled in a cassette by the use of filter paper and foam pads 
to ensure continuous contact between the two and at the same time access of the buffer 
everywhere in the assembly (see Schematic 1). Then, the cassette was assembled into 
a chamber according to manufacturer’s instructions, the chamber was filled with 1x 
Transfer buffer and a cooling unit and the blotting was done at 400 mA for 1.5 hours. 
After that, the membrane was ready to use for immunoblotting. 
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Schematic 1: The acrylamide gel and the nitrocellulose membrane were placed in the cassette 
as shown here. During the electrophoresis the proteins moved from the cathode to the anode 
thus attaching onto the solid substrate provided by the nitrocellulose.  
 
• 3.5.4 Immunoblotting 
Reagents and equipment: TBS-Tween 0.05%, blocking buffer, antibodies, ECL 
Western Blotting Substrate, tube roller, ChemiDocTM imaging system. 
 
Method description: Briefly, immunoblotting is based on the antibody-antigen 
recognition. After the proteins are fixed on nitrocellulose we use antibodies raised 
against a protein of interest. These antibodies are called primary and are being 
recognized by secondary antibodies which are raised in another species and recognize 
and bind onto heavy chains of the primary antibodies of the first species. In addition, 
the secondary antibodies are conjugated to an enzyme, namely horseradish peroxidase, 
which cleaves a chemiluminescent agent and the reaction product produces 
luminescence proportional to the amount of protein detected by the primary antibody.  
In this study, after the transfer was completed the nitrocellulose membranes were 
placed in 50 mL falcon tubes and blocked with blocking buffer for 1 hour at room 
temperature. This step was done on a tube roller at low speed. After the blocking step, 
the blocking buffer was removed and the primary antibody which was diluted 1:1000, 
apart from tubulin that was diluted 1:5000, in blocking buffer, was added in the tube 
containing the membrane. The incubation was done overnight at 4ºC at a low rolling 
speed. The next morning, the membranes were washed 3 times with TBS-Tween 
0.05% and the secondary antibody was added which was in each case diluted 1:3000. 
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The secondary antibody incubation lasted 1 hour at room temperature and before 
developing, the membrane was washed 3 times with TBS-Tween 0.05%.  
Before developing the membranes, each one was dried from the excessive TBS-Tween 
and covered with ECL for 1 minute. The membrane was then quickly placed between 
two pieces of transparent colorless plastic and put into a ChemiDocTM imaging system 
for development. The exposure lasted 30 seconds to 4 minutes depending on the 
strength of the signal. 
 
3.6 Neurite branch quantification 
Required software: ZEN software by Zeiss 
Method description: The ZEN software contains all the tools necessary for image processing 
and measurements. In our study, for every image the “Maximum Intensity Projection” option 
was firstly applied. This made the image analysis significantly faster since all the slices of a z-
stack could be projected into one single image. Under the tab “Overlay” the ZEN software has 
a number of tools by which lines of high accuracy can be drawn on the region of interest 
while the option of showing the size of each line within the image provides a full panel of 
measurements in relatively short time. In our case, the “Open Bezier” tool was used in order 
to measure the distance between 2º branches and the length of the body region imaged every 
time. The same tool was used to measure the total length of 3º branches for Figure 2e. 
 
3.7 Statistical analysis 
Required software: Prism by GraphPad Software 
Method description: In the case of comparing 2 groups, Student’s t-test was used. When 3 or 
more groups were compared, one-way ANOVA was used. All the results were expressed in 
mean± standard error. 
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Table 1 
Buffers/Media 
Buffer/Medium name Buffer/Medium recipe 
Bleaching solution 1% NaClO, 0.5 N NaOH 
Blocking buffer 
5% w/v non-fat dried milk in TBS-Tween 
0.05%  
Freezing solution 
S Buffer (see below), 30% glycerin (v/v) 
(autoclaved) 
Reducing Laemmli buffer 4x 
40% Glycerol, 250 mM Tris/HCl pH 6.8, 8% 
SDS, 0.04% bromophenol blue, 20% beta-
mercaptoethanol 
LB medium 
2% w/v of powder microbial growth medium 
(SIGMA) 
LB agar 1.5% w/v agar in LB medium  
Lower buffer 1.5 M Tris-base, 0.4% SDS, pH 8.8 
Lysis buffer 
50 mM KCl, 10 mM Tris-HCl (pH 8.1), 2.5 
mM MgCl2 (autoclaved) 
Mounting medium 
30% w/v polyethylene glycol 8000 in 25% 
v/v glycerol 
M9 buffer 
22 mM KH2PO4, 42 mM Na2HPO4, 85 mM 
NaCl,   1 mM MgSO4 
Nematode growth medium (NGM) 
50 mM NaCl, 1.7% w/v agar, 0.25% w/v 
peptone  
(autoclaved and when at ~55ºC the following 
were added:) 
1 mM CaCl2, 5 µg/mL cholesterol diluted in 
EtOH, 1 mM MgSO4, 25 mM KPO4 
PCR loading dye 10x  
100 mM EDTA pH 8.0, 1% w/v SDS, 50% 
v/v glycerol, 0.1% w/v bromophenol blue 
Running buffer 10x 
250 mM Tris 
1.92 M glycine 
1% SDS 
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S buffer 
6.45 mM K2HPO4, 43.55 mM KH2PO4 
0,1 M NaCl (autoclaved) 
Transfer Buffer 10x 
250 mM Tris 
1.92 M glycine 
(used 1x with 20% methanol) 
Tris-buffered saline (TBS) 10x 153 mM Tris.HCl, 1.4 M NaCl, pH 7.4 
Upper buffer 1M Tris-base, 0,4% SDS, pH 6.8 
 
* The chemicals were purchased from Applichem, Roth, SIGMA and VWR 
 
Table 2 
Reagents  
Reagent Company 
agarose SIGMA 
AICAR (5-Aminoimidazole-4-carboxamide 
ribonucleotide) 
Toronto Research Chemicals Inc. 
anti P-AMPK (T172) Cell Signaling 
anti-tubulin SIGMA 
APS (Ammonium persulfate) SIGMA 
Albumin Fraction V  Roth 
Bio-Rad protein assay Bio-Rad 
DNA ladder-100bp Applichem 
dNTPs Life Technologies 
ethidium bromide Applichem 
Escherichia coli OP50 Hengartner Lab 
filter paper Bio-Rad 
HRP-conjugated anti-mouse secondary antibody Thermo Fisher Scientific 
HRP-conjugated anti-rabbit secondary antibody Thermo Fisher Scientific 
PhosSTOP Tablets Roche 
Pierce ECL Western Blotting Substrate Thermo Scientific 
Protease Inhibitor Cocktail Tablets Roche 
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proteinase K Applichem 
Precision Plus Protein™ All Blue Standards  Bio-Rad 
RIPA buffer SIGMA 
Taq Polymerase (5 U/µL) Life Technologies 
TEMED (Tetramethylethylenediamine) Merck 
Tris/Borate/EDTA (TBE) buffer Applichem 
Tween20 Calbiochem 
Vitamin C SIGMA 
Whatman nitrocellulose  GE Healthcare Life Sciences 
10X PCR buffer Life Technologies 
30% (w/v) acrylamide/methylene bisacrylamide 
solution (37.5:1 ratio) 
National Diagnostics 
 
Table 3 
C. elegans Strains 
Strain name Genotype Source 
OH1422 otls138 [ser-2prom3::gfp; rol-6] CGC 
SK4005 zdIs5 [mec-4p::gfp; lin-15(+) (pSK1)] CGC 
nuo-6; otls138  nuo-6(qm200)I; otls138 [ser-2prom3::gfp; rol-6] Hekimi Lab 
BAN-54 gas-1(fc21)X; otls138 [ser-2prom3::gfp; rol-6] cross 
BAN-73 daf-2(e1370)III; otls138 [ser-2prom3::gfp; rol-6] cross 
BAN-74 aak-2(ok524)X; otls138 [ser-2prom3::gfp; rol-6] cross 
BAN-75 daf-2(e1370)III; gas-1(fc21)X; otls138 [ser-
2prom3::gfp; rol-6] 
cross 
BAN-83 gas-1(fc21)X; aak-2(ok524)X; otls138 [ser-
2prom3::gfp; rol-6] 
cross 
BAN-102 gas-1(fc21)X; zdIs5 [mec-4::gfp; lin-15(+) (pSK1)] cross 
BAN-105 age-1(hx546)II; otls138 [ser-2prom3::gfp; rol-6] cross 
BAN-117 age-1(hx546)II; gas-1(fc21)X; otls138 [ser-
2prom3::gfp; rol-6] 
cross 
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Table 4:  Primers 
 
gene allele 
Forward primer 
(5‘->3‘) 
Reverse primer 
(5‘->3‘) 
Annealing 
temperature (ºC) 
Amplicon size 
(bp) 
aak-2 wild type agtcatcagtacaccttctgacattttca agttgttgtgtctaatcttgttcaattactt 65 511 
aak-2 ok524 agtcatcagtacaccttctgacattttca agttgttgtgtctaatcttgttcaattactt 65 103 
age-1 wild type acccagtttgtacacaggatccagtag gaatatcgccgtatctcacttctgatgg 65 231 
age-1 hx546 acccagtttgtacacaggatccagtaa gaatatcgccgtatctcacttctgatgg 65 231 
clk-1 wild type agatgtgggatgaggagaaagaa cagtatcatgatgatgaagcgc 59 444 
clk-1 e2519 agatgtgggatgaggagaaagaa ccagtatcatgatgatgaagcgt 59 444 
daf-2 wild type aacacctcatcattactcaaaccaatatatag ggaagctaatattatgaagaactttaagactaacttta 57.5 500 
daf-2 e1370 caacacctcatcattactcaaaccaatatataa ggaagctaatattatgaagaactttaagactaacttta 57.5 500 
gas-1 wild type atacttcgatcgtctcgattacgtct ctgacacaagtccgatgtcaatagtac 58 420 
gas-1 fc21 atacttcgatcgtctcgattacgtct ctgacacaagtccgatgtcaatagtat 58 420 
isp-1 wild type caggagaaaaaagactgcataccaattag gtcaaactatcgtcgtgattctacaaaga 62 525 
isp-1 qm150 caggagaaaaaagactgcataccaattaa gtcaaactatcgtcgtgattctacaaaga 62 525 
nuo-6 wild type atgtagaagagagcgaaaacggtac tgataacatttgcgttgatgaaca 60 428 
nuo-6 qm200 atgtagaagagagcgaaaacggtat tgataacatttgcgttgatgaaca 60 428 
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Table 5 
Plasticware & Glassware 
Type of plasticware/glassware Company 
eppendorf tubes 1.5 mL/2 mL eppendorf 
falcon tubes 15 mL/50 mL BD Falcon 
strippetes 5 mL/ 10 mL/ 25 mL/ 50 mL Costar 
pipette tips 10 µl/ 200 µl/ 1000 µl VWR 
petri dishes 55 mm/90 mm diameter Nerbeplus 
0.2 mL PCR tubes Nerbeplus 
glass slides Th. Geyer 
coverslips (24x24mm) Menzel-Glaesser 
conical flasks /glass bottles/beakers Schott/VWR 
cuvettes VWR 
cryo tubes Thermo Scientific 
glassplates for acrylamide gels Bio-Rad 
gel holders and gel combs Bio-Rad 
 
Table 6 
Equipment 
Type of equipment Company 
bacterial incubator shaker Stuart 
Bunsen burner WLD-TEC 
chambers for gel electrophoresis and transfer Bio-Rad 
ChemiDocTM imaging system Bio-Rad 
confocal microscope Zeiss 
hot plate Grant 
nematode/bacterial incubators Binder 
platinum wire 0.2 mm (32 gauge) Neo Lab 
power supplies for electrophoresis VWR 
spectrophotometer eppendorf 
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stereomicroscope Leica M80 
stereomicroscope lamp KL1500 LCD 
thermocycler Bio-Rad/Biometra 
tube roller NeoLab 
ultrasonic disintegrator MSE 
UV lamp for agarose gel imaging Syngene 
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4. Results 
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4.1 Generation of a C. elegans model for in vivo analysis of neuronal 
remodeling 
In order to study the effects of mitochondrial dysfunction in neuronal architecture, we sought 
to find a model which would allow us fast imaging of its nervous system and flexibility in 
order to follow a genetic approach. These criteria are both fulfilled by the nematode C. 
elegans. C. elegans has a very well mapped nervous system and the animal’s transparency 
allows live imaging of its nervous system with great speed. C. elegans is also suitable for 
genetics since obtaining new mutants via crossing can be done in short time [44]. In addition, 
obtaining transgenic strains that carry an array which leads the expression of a fluorescent 
protein in a group or a single neuron is simple: such strains can be obtained by the 
Caenorhabditis Genetics Center (CGC) or generated in house by generating 
extrachromosomal arrays via the microinjection method [56]. 
After selecting the model organism, we tried to indentify a neuron which could give an easy 
readout regarding neuronal architecture and remodeling. Although most of the C. elegans 
neurons are structurally simple and have unbranched projections [57], two pairs of neurons, 
the FLPs and the PVDs, have complex dendritic branches. The PVDs are mechanosensory 
neurons that have an extensive elaborate branching which envelops almost the entire body of 
the adult animal and its pattern is consistent between different individuals (Figure 1a) [57, 
69]. The dendritic arborizations of these neurons comprise of repetitive structural units which 
resemble menorahs, hence their name. Overall, we started our study by selecting the PVD 
neurons as a model that would allow us to assess easily differences in neuronal architecture.  
In order to visualize the PVDs we selected a transgenic C. elegans strain, namely OH1422, 
which carries an integrated transgene (ser-2prom3::gfp) driving the expression of GFP under 
the promoter 3 of ser-2 (serotonin/octopamine receptor) [87]. This results into GFP 
expression in the PVDs, and two other mechanosensory neurons the OLLs and the PDEs. 
Since the PDE and the OLLs do not interfere with the branching pattern of the PVD, imaging 
of the latter was easily performed. 
The stage we selected for imaging was day 4 after hatching which corresponds to the first day 
of adulthood (animals capable of laying eggs) when the animals are kept at 20ºC (apart from 
nuo-6 mutants that need 7 days to molt into adults-see below). At this stage the PVDs are 
fully developed and therefore that is the stage we selected for imaging. As previously 
mentioned, the PVDs envelop the entire body of the adult worm. Therefore, in order to 
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accelerate our experiments both in terms of image acquisition and analysis, we focused on the 
posterior area of the body which was defined by the position the neuronal cell body to the end 
of the tail (Figure 1a). This area has the advantages of reduced interference of the eggs carried 
by adult animals with the imaging process, as well as reduced endogenous fluorescence which 
is redundant due to granules in the intestine or accumulated lipid particles in more anterior 
areas of the body. In addition, this part of the neuron represents more than 1/3 of the entire 
dendritic arborization, thus rendering the captions we studied representative of the 
organization of the entire neuron. 
Nextly, we identified which were the traits of the PVD neuron we could measure and 
eventually use as readouts. Indeed, as indicated by our results, the number of 2º branches, the 
distance between them as well the same values for the 3º branches proved to be 
morphological properties of the neuron and are consistently altered under specific conditions 
(Figure 1b). Finally, for the needs of a certain experiment we used as readout the total length 
of 3º branch for the menorahs present in the area or interest (Figure 2e, see text for more 
information). 
Overall, in the first phase of our study we established an in vivo model which would allow us 
to monitor easily and precisely neuronal remodeling and a great number of manipulations 
including the application of a genetic approach. 
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Figure 1: Establishment of an in vivo model to monitor neuronal remodeling. a) PVD neuron 
of a young adult animal (day 4). The dashed rectangle indicates the area of interest. Scale bar 
represents 50 µm. b) Schematic of part of the PVD neuron with indications of the variable 
traits we measured in this study. 
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4.2 OXPHOS impairment alters dendritic arborization in C. elegans 
sensory neurons 
In order to study the effect of mitochondrial deficiency on the morphology of C. elegans 
neurons, we selected a mitochondrial mutant, namely gas-1(fc21). gas-1 mutants are known to 
have altered sensitivity to volatile anesthetics, fecundity and reduced lifespan [88]. The gas-1 
gene encodes for a 49 kDa iron protein subunit of the mitochondrial Complex I. GAS-1 is 
widely expressed in the nematode neuromuscular system [89]. Animals carrying the fc21 
allele have reduced Complex I enzymatic activities as shown by measurements of oxidative 
phosphorylation and electron transport [89].  
Indeed, analysis of the neuronal morphology of gas-1 mutant animals carrying the integrated 
transgene ser-2prom3::gfp which drives gfp expression in the PVD neuron, showed altered 
dendritic pattern compared to wild type animals (Figure 2a). Specifically, gas-1 animals had 
significantly more 2º branches than wild type animals in the same body region (Figure 2b). 
All our measurements were normalized to the length of the measured area in order to exclude 
the detection of differences due to differences in body size. In order to confirm the increased 
density of dendritic arbors in gas-1 mutants, we also measured the distance between the 2º 
and 3º branches (Figure 2c-d). In agreement with our previous observation, the 2º branches 
occurred with almost a double frequency in gas-1 mutants compared to wild type animals. 
Thus, our analysis suggests that Complex I impairment promotes branching. In addition, the 
total length of 3º branches is not affected in gas-1 mutants (Figure 2e) -a fact that indicates an 
altered neuronal architecture with each menorah covering a smaller receptive field in these 
mutants. 
After examining the phenotype of gas-1 mutant animals, we wanted to determine whether it 
occurred specifically in this strain or other mutations causing OXPHOS impairment could 
have the same effect. To that end, we examined the neuronal morphology of a mutant strain 
overexpressing the transgene ser-2prom3::gfp, namely nuo-6(qm200). nuo-6 encodes for the 
NDUFB4/B15 subunit of complex I [90]. Mutants carrying the qm200 allele have been shown 
to have increased longevity -an effect caused by elevated levels of superoxide produced by 
their mitochondria [91]. In line with our evidence in gas-1 mutants, nuo-6 mutant nematodes 
exhibited significantly increased branching as demonstrated by the increased number of 2º 
branches and their increased density (Figure 2f-g).  
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Since animals carrying OXPHOS defects exhibit enhanced oxidative stress [90, 92] we 
wondered if treatment of gas-1 mutant animals with an anti-oxidant would ameliorate the 
phenotype. As shown in Figure 2h, treatment of gas-1 mutant nematodes with the antioxidant 
Vitamin C [93] did not rescue the phenotypic anomaly. This is in accordance with existing 
evidence showing that treatment with oxidants such as paraquat and hydrogen peroxide, did 
not affect the branching of certain neurons in C. elegans in a manner similar to OXPHOS 
mutants [62]. 
In summary, OXPHOS impairment alters dendritic morphology in the PVD neuron and this 
effect is independent of the mutation causing the OXPHOS impairment and uncoupled from 
increased oxidative stress. 
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Figure 2: Mitochondrial complex I deficiency results in increase of branching of C. elegans 
sensory neurons. a) Representative confocal images (left panel) and their schematic tracing 
(right panel) of wild type (W) and gas-1(fc21) mutant nematodes overexpressing the ser-
2prom3::gfp transgene. Scale bars represent 25 µm. b) Quantification of 2º branches 
normalized to body length in wild type and gas-1 mutant nematodes. c) Quantification of the 
distance between neighboring 2º branches in wild type and gas-1 mutant animals. d) 
Quantification of the distance between neighboring 3º branches in wild type and gas-1 
animals. e) Quantification of the total length of 3º branches in wild type animals and gas-1 
mutants. f) Quantification of 2º branches normalized to body length in wild type and nuo-
6(qm200) mutant nematodes. g) Quantification of the distance between neighboring 2º 
branches in wild type and nuo-6 animals. h) Quantification of 2º branches normalized to body 
length in untreated and treated with 1 mM Vitamin C wild type and gas-1 mutant nematodes. 
****P<0.0001, ***P=0.0001, **P<0.001, one-way ANOVA (panel H) or Student’s t-test; 
n=3 for each set of experiments. 
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4.3 Neuronal remodeling due to OXPHOS impairment is not cell-type 
specific 
Based on our analysis, it is clear that OXPHOS impairment affects the architecture of the 
dendrites of the PVD neurons in C. elegans. What we wondered next was whether this effect 
is cell-type specific. 
To that end we examined the morphology of a pair of light touch receptor neurons, the PLMs. 
These neurons have their cell bodies located in the tail and have a single process that projects 
anteriorly (Figure 3a). We specifically used a strain that overexpresses the integrated mec-
4p::gfp transgene [94] and imaged the PLM neurons both in wild type and gas-1 mutant 
animals. Our analysis revealed that while wild type animals rarely have ectopic structures on 
their PLM projections, gas-1 mutant nematodes of the same stage demonstrated almost a two-
fold increase in extra protrusions (Figure 3b). 
In conclusion, the alterations in neuronal morphology due to OXPHOS impairment occur in 
C. elegans neurons in a cell-type independent manner. 
 
Figure 3: OXPHOS impairment affects the morphology of neurons in a non-cell type specific 
manner. a) Representative confocal image of a wild type animal (left panel) overexpressing 
the mec-4p::gfp transgene. Scale bar represents 50 µm. Representative confocal images (right 
panel) of a part of the PLM neuron of a wild type animal and a gas-1 mutant nematode 
overexpressing the mec-4p::gfp transgene. The arrows indicate the ectopic processes. Scale 
bars represent 10 µm. b) Quantification of ectopic outgrowths in PLM neurons in wild type 
(W) and gas-1 (G) mutants. *P<0.05, Student’s t-test; n=3. 
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4.4 AMPK activity regulates dendritic branching 
Nextly, we wondered which are the molecules that mediate excessive branching due to 
OXPHOS defects in nematodes. We considered as potential candidates molecules 
participating in signaling pathways that get activated due to energy deprivation as a 
consequence of OXPHOS impairment. AMP-activated protein kinase (AMPK) is a promising 
candidate since it is an energy sensor involved in many catabolic processes engaged during 
stress, including conditions of altered mitochondrial respiration [95, 96]. Specifically, 
decreased energy levels promote the binding of AMP to AMPK. This causes an allosteric 
activation that allows the phosphorylation or Thr172 in the alpha-kinase domain by upstream 
kinases like LKB1 or CaMKKbeta [97]. 
In C. elegans aak-1 and aak-2 encode two homologs of the alpha-catalytic subunit of the 
human AMPK, with AAK-2 participating in stress-response signaling pathways due to energy 
deprivation [98, 99]. We assessed the phosphorylation levels of C. elegans AMPK via 
western blot and observed significantly increased levels of phosphorylated AMPK in 
homogenates of gas-1 animals compared to wild type (Figure 4a). As shown by the 
immunoblot, the lack of signal for aak-2-null mutant animals indicates that AAK-2 is the 
main phosphorylated AMPK (Figure 4a). 
Considering the levels of AMPK phosphorylation under OXPHOS impairment conditions, we 
wanted to assess the role of AMPK in the excess branching observed in gas-1 mutant 
nematodes. For that purpose we generated a double mutant strain gas-1; aak-2 overexpressing 
the PVD fluorescent reporter. Analysis of the neuronal morphology of these double mutant 
nematodes revealed that the number of menorahs, 2º branches as well as the distance between 
them had no significant difference with their wild type counterparts (Figure 4b-d). This 
suggests that AAK-2/AMPK is required to induce branching due to OXPHOS deficiency. 
On the basis of these observations, we hypothesized that overactivation of AAK-2/AMPK 
would mimic the conditions of OXPHOS impairment and lead to a similar enhancement of 
dendritic branching. In order to confirm our hypothesis, we treated nematodes with 5-amino-
imidazole-carboxamide riboside (AICAR). AICAR is an AMP mimetic that binds and 
activates AMPK and has been suggested as a treatment for mitochondrial disorders [100]. In 
accordance with our previous results, treatment with AICAR induced dendritic branching in 
wild type nematodes but it had no effect on gas-1 mutants (Figure 4f). The specificity of 
AICAR was confirmed via western blot where we observed an increase in the levels of 
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phosphorylated AMPK for wild type animals and detected no phosphorylated AMPK for aak-
2-null mutants (Figure 4e). Additionally, the lack of effect of AICAR on the number of 
dendritic branches of aak-2-null mutants further confirmed the specificity of the compound 
(Figure 4g).  
Overall, our observations suggest that the enhanced dendritic branching associated with 
mitochondrial OXPHOS deficiency in nematodes is mediated by the phosphorylated AAK-
2/AMPK. 
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4.5 PI3K/AGE-1 acts downstream of AMPK to regulate dendritic 
arborization 
In search of molecular actors that can act downstream of AMPK and be involved in dendritic 
branching, we examined the role of phosphoinositide 3-kinase (PI3K). This protein belongs to 
a family of intracellular signal transducer enzymes capable of phosphorylating the 3 position 
hydroxyl group of the inositol ring of phosphatidylinositol. In addition, PI3K has been 
involved in axonal neurite growth during polarization of mammalian hippocampal neurons 
localizing to the tip of newly specified axons [101, 102]. Interestingly, activated AMPK can 
disrupt the association of PI3K with the kinesin Kif5 and consequently prevent the targeting 
of PI3K to the axonal tip. By extension, this inhibits neuronal polarization and axon growth 
[103]. Thus, we sought to investigate if PI3K is involved in the phenotype of excessive 
branching in our OXPHOS mutants. 
In C. elegans, age-1 encodes for the homolog the p110 catalytic subunit of the mammalian 
PI3K [104]. To determine if PI3K has a role in dendritic outgrowth, we generated C. elegans 
strains carrying a loss-of-function allele (hx546) of the age-1 gene. In line with our working 
hypothesis, age-1 loss-of-function suppressed completely the increased dendritic branches 
induced by OXPHOS impairment as shown by the analysis of the neuronal morphology 
conducted on age-1; gas-1 double mutants (Figure 4b-c). 
Finally, we wanted to determine whether AAK-2 acts upstream of AGE-1. To that direction 
we treated age-1 mutant animals with AICAR. We hypothesized that if AAK-2/AMPK acts 
upstream of AGE-1/PI3K, AICAR treatment would not promote dendritic branching in these 
mutants. In support of our hypothesis, age-1-loss-of-function suppressed significantly the 
effect of AICAR (Figure 4h). 
Collectively, our findings indicate that AGE-1/PI3K is involved in the formation of excessive 
dendritic branches induced by AAK-2/AMPK hyperphosphorylation and it specifically acts 
downstream of the latter. 
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Figure 4: AMPK regulates dendritic branching in nematodes with impaired OXPHOS 
through PI3K: a) Western blot showing the protein levels of phosphorylated AMPK (T172) 
(and tubulin as a loading control) in extracts from wild type (W), gas-1 (G), aak-2 (A) and 
gas-1; aak-2 (G;A) mutant nematodes (n=1). b-c) Quantification of number of menorahs (b) 
and number of 2º branches (c) normalized to the body length in wild type, gas-1, aak-2, gas-
1; aak-2, age-1 and age-1; gas-1 mutants. d) Quantification of the distance between 
neighboring 2º branches in wild type, gas-1, aak-2, gas-1; aak-2, age-1 and age-1; gas-1 
mutants. e) Western blot showing the protein levels of phosphorylated AMPK (T172) (and 
tubulin as loading control) for untreated and treated with 1 mM AICAR wild type (W), gas-1 
(G) age-1 (Ag) and aak-2 (A) mutant nematodes (n=1). f) Number of 2º branches normalized 
to the body length in wild type and gas-1 mutant nematodes untreated or treated with 1 mM 
AICAR. g) Number of normalized 2º branches in aak-2 mutant animals untreated or treated 
with 1 mM AICAR. h) Number of 2º branches normalized to the body length in wild type and 
age-1 mutant animals untreated or treated with 1 mM AICAR. ****P<0.0001, ***P<0.001, 
**P<0.01, *P<0.05, one-way ANOVA, n=3 (unless otherwise indicated) for each set of 
experiments, 15-30 animals per condition were analyzed in total.  
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4.6 OXPHOS impairment-induced dendritic branching is uncoupled from 
accelerated aging 
Age-related increase of dendritic branching has been previously reported in C. elegans. 
Specifically, it was shown that sensory neurons of aged animals had higher probability of 
displaying newly formed ectopic outgrowths compared to their younger counterparts [62, 63]. 
Since our study revealed a similar effect due to OXPHOS impairment, we sought to determine 
whether the observed phenotype was linked to accelerated ageing of the short-lived OXPHOS 
mutants. 
For this purpose, we assessed the morphology of the PVD neuron in the long lived daf-2 
mutant animals carrying the ser-2prom3::gfp integrated transgene. The daf-2 gene encodes 
for the sole insulin/IGF-1 receptor in C. elegans and mutants carrying the hypomorphic allele 
e1370 display prolonged lifespan [105]. We demonstrated that daf-2(e1370) mutant 
nematodes have increased phosphorylation levels of AMPK as shown in the immunoblot of 
Figure 5a. Assessment of their neuronal morphology revealed that daf-2 mutants have 
significantly increased 2º branches as well as decreased distance between them (Figure 5b-c). 
Importantly, daf-2; gas-1 double mutants which live longer than the individual single mutants 
(Troulinaki et al, manuscript in preparation), also have significantly increased number of 2º 
branches and decreased distances between them (Figure 5b-c).  
In order to further support our findings, we assessed the morphological alterations that occur 
in the PVD neuron due to ageing. As shown in Figures 5d-f, the morphological alterations that 
present on day 6 and deteriorate by day 10 are not similar to the dendritic alterations we report 
in mutant strains having OXPHOS impairments. Six days after hatching the PVD displays a 
significant increase of randomly distributed ectopic outgrowths and loss of distinction 
between neighboring menorahs (Figure 5f). This phenotype is more pronounced as the 
animals age further. Indeed, 10 days after hatching the loss of distinction between neighboring 
menorahs is significantly increased (Figure 5e). This type of structural alteration differs from 
the dendritic alterations we found in gas-1 or nuo-6 mutants and it supports even further the 
uncoupling of OXPHOS impairment-induced dendritic branching from accelerated aging.  
Overall our findings indicate that alterations of the ageing pace or lifespan are not 
contributing factors to the excessive branching due to OXPHOS compromise. This is in line 
with our observation that nuo-6 mutants that have OXPHOS impairment but live longer 
compared to wild type animals, still display increased number of dendritic branches.  
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Figure 5: OXPHOS impairment-induced dendritic branching is uncoupled from accelerated 
aging. a) Western blot of phosphorylated AMPK (T172) and tubulin in samples from wild 
type (W), daf-2 (D) and daf-2; aak-2 (D;A) mutant nematodes (n=1). b) Measurement of the 
number of 2º branches normalized to the body length in wild type, gas-1, daf-2 and daf-2; 
gas-1 mutant nematodes. c) Quantification of the distance between 2º branches in wild type, 
gas-1, daf-2 and daf-2; gas-1 mutant nematodes. d,e) Measurement of ectopic branches of 4, 
6 and 10 days old wild type animals normalized to the body length (d) and quantification of 
the gaps separating neighboring menorahs (e) (n=2). f) Representative images of the PVD 
neuron in 4, 6 and 10 days old wild type animals. The asterisks in the insert indicate the 
contact between neighboring menorahs and the arrows indicate ectopic branches.  Scale bars 
of the images and of the insert represent 25 µm. ****P<0.0001, ***P<0.001, **P<0.01, ns= 
not significant, one-way ANOVA, n=3 (unless otherwise indicated) for each set of 
experiments and 15-20 animals per condition were analyzed in total. 
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5. Discussion 
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Multiple lines of evidence implicate mitochondrial deficiency in several neurodegenerative 
diseases [106]. The mechanisms linking mitochondrial deficiency neurodegeneration are not 
yet clear. In the present study, we studied the neuronal morphology of mitochondrial deficient 
nematodes. We identified a signaling pathway that connects mitochondrial impairment with 
altered neuronal architecture. Specifically, we showed that C. elegans mutant strains lacking 
the mitochondrial Complex I display increased dendritic arborizations of their 
mechanosensory neurons in a non-cell-type specific manner. Given that the increased 
dendritic branching is not abolished by treatment with antioxidants, we ruled out that 
increased oxidative stress participates in this process. The observed branching potentiation is 
being regulated by a signaling pathway formed by AMP-activated protein kinase and PI3 
kinase. Finally, our findings demonstrate that the increased neuronal branching of OXPHOS 
impaired animals is uncoupled from accelerated ageing. 
In our study we demonstrated that the potentiation of branching in OXPHOS impairment 
conditions is mediated by the AMPK/PI3K axis. This is in agreement with previous findings 
showing that these two proteins can regulate neuronal branching in other systems. For 
example, overexpression of the serine threonine kinase LKB1 controls axon specification and 
branching through the activation of the AMPK-like kinase NUAK1 and the consequent 
immobilization of mitochondria at the nascent presynaptic site [28]. Although the role of 
AMPK activation in neuronal polarization, axogenesis and axon growth has been a topic of 
debate, overall the general notion is that AMPK activation levels affect neuronal polarization 
[107, 108]. Furthermore, AICAR-mediated AMPK activation prevents PI3K localization and 
Akt activity at the neurite tips during development. This results into suppression of axonal 
growth and neuronal polarization [103]. Although we also showed the involvement of PI3K, 
AMPK overactivation due to AICAR treatment in our setting led to excessive branching 
rather than reduced polarization. The difference between our and the aforementioned findings 
could derive from differences in the two studied models (C. elegans mechanosensory neurons 
versus hippocampal neurons) as well as the focus of the cellular compartment (dendrites 
versus axons). 
AMPK has a great variety of downstream targets [109]. One that is of high interest is the 
peroxisome proliferator-activated receptor γ co-activator 1α (PGC-1α) which is a master 
regulator of mitochondrial biogenesis [110-112]. Multiple lines of evidence suggest that 
AMPK activates this factor thereby increasing mitochondrial biogenesis [113-115]. Although 
the C. elegans genome lacks the orthologs of PGC-1α proteins [116], according to the above 
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evidence, one of our speculations is that activation of AMPK (in our setting either via AICAR 
treatment or mitochondrial deficiency) could activate the protein(s) that have a PGC-1α-like 
function in C. elegans [117]. This could be one of the reasons underlying the excessive 
neuronal branching since PGC-1α is also involved in the formation and maintenance of 
neuronal dendritic spines in mammalian neurons [118]. The hypothesis of the involvement of 
an AMPK-activated protein stimulating mitochondrial biogenesis would fit for a second 
reason: increased mitochondrial numbers could contribute to the increase of immobilized 
mitochondria that are capable of inducing branching formation as discussed above [28]. 
Overall, AMPK serves as an energy sensor and low energy levels can activate it leading to 
increased glucose transport, fatty acid oxidation and mitochondrial biogenesis [119]. As 
shown in our study, AMPK is activated as a response to mitochondrial deficiency. Since 
mitochondrial deficiency is increasingly linked to neurodegenerative diseases [120, 121], the 
consequential activation of AMPK is considered important as a therapeutic target. Indeed, 
AMPK can be pharmacologically modulated [122] and its involvement in neurodegeneration 
has been extensively studied [123]. For example, several studies have shown that by treating 
mouse models of Alzheimer’s disease with AMPK activators can upregulate the expression of 
autophagy-related proteins and improve their memory (reviewed in [124]). Our findings prove 
the connection of mitochondrial deficiency with AMPK activation, highlight the role of 
AMPK in neuronal architecture –which is affected during neurodegeneration [12, 13]- and 
show how mitochondrial deficiency, which can occur in neurodegenerative diseases, triggers 
a metabolic pathway that alters the shape of neurons. 
Formation of additional dendritic branches under energy deprivation circumstances caused by 
mitochondrial impairment is rather counterintuitive. Perhaps changes in the mitochondrial 
network due to the respiratory deficiency might affect dendritic branching. Alternatively, 
growth of additional dendritic branches could be the result of compensation due to reduced 
functionality of the neuron. This could be attributed to the reduced activity of channels on the 
surface of the neuron which can enhance branching of the neuron.  
Regarding the first interpretation about changes in mitochondrial network, it has been shown 
that Complex IV deficiency can lead to mitochondrial hyperfusion [125]. Such an event can 
deprive the cells of small motile mitochondria, which in the case of the highly polarized 
neuronal cells are of high importance. Indeed, increased mitochondrial fusion affects the 
formation of neurites and spines as demonstrated in mammalian neurons [24]. Similarly, in 
our setting, increased mitochondrial fusion of Complex I mutants can be a contributing factor 
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to the increased (in the case of PVD neurons) or ectopic (in the case of PLM neurons) 
branching. In addition, mitochondrial motility can affect neuronal morphology. According to 
observations from cortical neurons both in vivo and in vitro, immobile mitochondria can 
stimulate branching whereas mobile mitochondria lack this capacity [28]. Indeed, the 
presence of mitochondria in presumptive branching points facilitates the energy required for 
protein synthesis and calcium buffering, which contributes to actin-dependent branching 
initiation [126]. In our experimental setup, comparison of mitochondrial dynamics, trafficking 
and size in the neurons of wild type and OXPHOS impairment mutants could give more 
information on the validity of this hypothesis. 
Our alternative hypothesis on the increased branching as a process to compensate reduced 
functionality is interesting, yet difficult to confirm. It has been demonstrated that reduced 
voltage activated channel activity in sensory neurons can potentiate excessive branching in 
certain neurons of C. elegans [127, 128]. This is explained by the reduced sensitivity of the 
neuron which is incapable of recognizing its final target and therefore receiving the signals 
that inhibit its growth. The voltage activated channels require Ca2+ buffering [129] to which 
mitochondria significantly contribute. On the basis of evidence indicating that under 
conditions of mitochondrial deficiency, mitochondria have altered Ca2+ buffering capacity 
[130], the function of voltage gated channels could be compromised thus resulting in lack of 
sensitivity of the neuron and consequent excessive or ectopic branching. Addressing this 
question in our setup can be quite challenging. A potential approach would be the generation 
of a transgenic C. elegans strain overexpressing a channelrhodopsin and a genetically encoded 
Ca2+ reporter in the PVD neurons. Light stimulation of the channelrhodopsin-expressing PVD 
neuron would cause a Ca2+ transient in the neuron which can be measured by a genetically 
encoded Ca2+ reporter [131, 132]. Assuming that the enhanced neuronal branching in 
OXPHOS mutants is a compensatory mechanism one would expect to see comparable 
neuronal activities between wild type and OXPHOS impairment mutants. Nevertheless, this 
would indicate that the excessive branching is a compensatory mechanism and would not 
prove it since perhaps the neuronal functionality of OXPHOS mutants is not affected. One 
way to overcome this obstacle would be to compare neuronal activities between aak-2 and 
gas-1; aak-2 mutants. aak-2 mutants have neurons structurally comparable to wild type 
animals and additionally the gas-1; aak-2 double mutants, although they are OXPHOS 
mutants do not display extra dendritic arborizations. If the excessive branching is indeed 
compensating for functionality loss, gas-1; aak-2 double mutants should display reduced 
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activity compared to aak-2 single mutants since the aak-2 mutation in the gas-1 genetic 
background inhibits the formation of excessive neuronal outgrowths. 
Apart from the two main speculation lines discussed above, several other scenarios are 
possible. For instance, the observed branching potentiation due to OXPHOS impairment 
could be the result of the combination of various factors. Perhaps the expression of molecules 
regulating dendritic branching is affected. In addition, our data do not clarify if the observed 
effect is cell- or non cell-autonomous. Therefore, a deeper analysis of the contribution of 
branching regulators in the observed phenotype could partly elucidate the relation between 
metabolic changes and cell shaping molecules. To that end, determining if the altered 
neuronal architecture of OXPHOS mutants is a cell or non-cell autonomous phenomenon 
could indicate whether the cell shaping molecules participating in the remodeling act in an 
intra- or extracellular manner. 
Finally, our data demonstrate that the increased neuronal branching due to mitochondrial 
deficiency is not related to ageing. Other studies have also shown that ageing affects neuronal 
branching in C. elegans and this alteration is characterized by the presence of extra neuronal 
processes on touch receptor neurons [62, 63]. Tank et al. observed accelerated neurite 
branching in short-lived mitochondrial deficiency mutant animals and they attributed that to 
the accelerated ageing. In addition, they showed that long-lived mitochondrial mutants exhibit 
delayed onset of extra neuronal projections. Nevertheless, we showed that young adult 
animals with similar mitochondrial deficiencies have extra neuronal processes and this occurs 
regardless of their lifespan duration. The contradiction between the two studies could be due 
to the fact that Toth et al. do not provide measurements of young adult animals that carry 
mitochondrial deficiencies, but only measurements from day 10 adult animals. Examining 
neuronal morphology of animals this stage could lead to a misinterpretation of the presence of 
ectopic neuronal projections as an effect of accelerated ageing and not of mitochondrial 
deficiency. 
The remarkable age-related phenotype of the PVD neuron is quite intriguing. Ageing is 
associated with cognitive function decline in humans, and this can be partly explained by 
alterations in neuronal morphology of the ageing brain. Although the concept of extra 
neuronal processes forming due to ageing seems counterintuitive, it has been reported that in 
some brain areas of humans the dendritic extent of neurons can be greater in aged individuals 
compared to younger ones [133, 134]. Since the C. elegans nervous system demonstrates 
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similar changes, it could be used as a model to reveal the mechanisms underlying age-related 
alterations of neuronal architecture. 
In summary, with this work we developed and described a new animal model for the analysis 
of dendritic branching under conditions of OXPHOS impairment. We revealed a novel 
signaling pathway that regulates neuronal branching under mitochondrial deficiency 
conditions, although more work is required to uncover the rest of the players participating in 
this signaling cascade. A closer look at mitochondrial dynamics, trafficking, and the role of 
neuronal branching regulators could potentially yield conclusions relevant for the elucidation 
of mechanisms underlying neurodegenerative diseases.   
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6. List of abbreviations 
ADP: Adenosine diphosphate 
AICAR: 5-Aminoimidazole-4-carboxamide ribonucleotide 
AMP: Adenosine monophosphate 
AMPK: AMP-activated protein kinase 
APL-1: Amyloid precursor-like 
APP: Amyloid precursor protein 
APS: ammonium persulfate 
ATP: Adenosine triphosphate 
Aβ: Amyloid beta 
BSA: Bovine serum albumin 
C. elegans: Caenorhabditis elegans 
CPEB1: Cytoplasmic Polyadenylation Element Binding Protein 1 
DNA: Deoxyribonucleic acid 
dNTPs: Deoxynucleotides triphosphates 
ECL: Enhanced chemiluminescence 
E. Coli: Escherichia coli 
et al.: And others (“et alii”) 
GFP: Green fluorescent protein 
HTT: huntingtin 
LacZ: β-galactosidase of the lactose operon 
LB: Lysogeny broth 
LKB1: Liver kinase 1 
mL: milli liter 
mm: milli meter 
mRNA: messenger RNA (Ribonucleic acid) 
mV: mili volt 
NGM: nematode growth medium 
nm: nano meter 
OXPHOS: Oxidative phosphorylation 
PAGE: Polyacrylamide gel electrophoresis 
PCR: Polymerase chain reaction 
PGC-1α: Peroxisome Proliferator-activated receptor γ co-activator 1α 
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PI3K: Phosphatidylinositol-4,5-biphosphate 3-kinase 
RIPA: Radio-immunoprecipitation assay 
RNAi: RNA interference 
rpm: rounds per minute 
SDS: sodium dodecyl sulfate 
Taq: Thermus aquaticus 
TBE: Tris/Borate/EDTA 
TBS: Tris-buffered saline 
TEMED: Tetramethylethylenediamine 
U: Unit 
ZEN: Zeiss efficient navigation 
µL: micro liter 
µM: micro molar 
% (v/v): volume/volume percentage 
% (w/v): weight/volume percentage 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
63 
 
7. References 
1. Andres-Barquin, P.J., Ramon y Cajal: a century after the publication of his 
masterpiece. Endeavour, 2001. 25(1): p. 13-7. 
2. Yoshimura, T., N. Arimura, and K. Kaibuchi, Molecular mechanisms of axon 
specification and neuronal disorders. Ann N Y Acad Sci, 2006. 1086: p. 116-25. 
3. Lalli, G., Regulation of neuronal polarity. Exp Cell Res, 2014. 
4. Lewis, T.L., Jr., J. Courchet, and F. Polleux, Cell biology in neuroscience: Cellular 
and molecular mechanisms underlying axon formation, growth, and branching. J Cell 
Biol, 2013. 202(6): p. 837-48. 
5. Tau, G.Z. and B.S. Peterson, Normal development of brain circuits. 
Neuropsychopharmacology, 2010. 35(1): p. 147-68. 
6. McKhann, G.M., Changing concepts of Alzheimer disease. JAMA, 2011. 305(23): p. 
2458-9. 
7. Turner, R.S., et al., Amyloids beta40 and beta42 are generated intracellularly in 
cultured human neurons and their secretion increases with maturation. J Biol Chem, 
1996. 271(15): p. 8966-70. 
8. Mandelkow, E.M. and E. Mandelkow, Tau in Alzheimer's disease. Trends Cell Biol, 
1998. 8(11): p. 425-7. 
9. Brown, R.G. and C.D. Marsden, Cognitive function in Parkinson's disease: from 
description to theory. Trends Neurosci, 1990. 13(1): p. 21-9. 
10. Forno, L.S., Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol, 1996. 
55(3): p. 259-72. 
11. Thomas, B. and M.F. Beal, Parkinson's disease. Hum Mol Genet, 2007. 16 Spec No. 
2: p. R183-94. 
12. Arendt, T., et al., Dendritic reorganisation in the basal forebrain under degenerative 
conditions and its defects in Alzheimer's disease. II. Ageing, Korsakoff's disease, 
Parkinson's disease, and Alzheimer's disease. J Comp Neurol, 1995. 351(2): p. 189-
222. 
13. Krstic, D. and I. Knuesel, Deciphering the mechanism underlying late-onset Alzheimer 
disease. Nat Rev Neurol, 2013. 9(1): p. 25-34. 
14. Rikani, A.A., et al., The mechanism of degeneration of striatal neuronal subtypes in 
Huntington disease. Ann Neurosci, 2014. 21(3): p. 112-114. 
15. Roze, E., et al., Huntington's disease. Adv Exp Med Biol, 2010. 685: p. 45-63. 
16. Graveland, G.A., R.S. Williams, and M. DiFiglia, Evidence for degenerative and 
regenerative changes in neostriatal spiny neurons in Huntington's disease. Science, 
1985. 227(4688): p. 770-3. 
17. Ferrante, R.J., N.W. Kowall, and E.P. Richardson, Jr., Proliferative and degenerative 
changes in striatal spiny neurons in Huntington's disease: a combined study using the 
section-Golgi method and calbindin D28k immunocytochemistry. J Neurosci, 1991. 
11(12): p. 3877-87. 
18. Mayeux, R., Epidemiology of neurodegeneration. Annu Rev Neurosci, 2003. 26: p. 
81-104. 
19. Beal, M.F., Mitochondrial dysfunction in neurodegenerative diseases. Biochim 
Biophys Acta, 1998. 1366(1-2): p. 211-23. 
20. Mitchell, P., Chemiosmotic coupling in oxidative and photosynthetic phosphorylation. 
1966. Biochim Biophys Acta, 2011. 1807(12): p. 1507-38. 
21. Oruganty-Das, A., et al., Translational control of mitochondrial energy production 
mediates neuron morphogenesis. Cell Metab, 2012. 16(6): p. 789-800. 
64 
 
22. Lackner, L.L., Shaping the dynamic mitochondrial network. BMC Biol, 2014. 12: p. 
35. 
23. Scott, S.V., et al., Staying in aerobic shape: how the structural integrity of 
mitochondria and mitochondrial DNA is maintained. Curr Opin Cell Biol, 2003. 
15(4): p. 482-8. 
24. Li, Z., et al., The importance of dendritic mitochondria in the morphogenesis and 
plasticity of spines and synapses. Cell, 2004. 119(6): p. 873-87. 
25. Ishihara, N., et al., Mitochondrial fission factor Drp1 is essential for embryonic 
development and synapse formation in mice. Nat Cell Biol, 2009. 11(8): p. 958-66. 
26. Chen, H., J.M. McCaffery, and D.C. Chan, Mitochondrial fusion protects against 
neurodegeneration in the cerebellum. Cell, 2007. 130(3): p. 548-62. 
27. Glater, E.E., et al., Axonal transport of mitochondria requires milton to recruit kinesin 
heavy chain and is light chain independent. J Cell Biol, 2006. 173(4): p. 545-57. 
28. Courchet, J., et al., Terminal axon branching is regulated by the LKB1-NUAK1 kinase 
pathway via presynaptic mitochondrial capture. Cell, 2013. 153(7): p. 1510-25. 
29. Lin, M.T. and M.F. Beal, Mitochondrial dysfunction and oxidative stress in 
neurodegenerative diseases. Nature, 2006. 443(7113): p. 787-95. 
30. DiMauro, S. and E.A. Schon, Mitochondrial respiratory-chain diseases. N Engl J 
Med, 2003. 348(26): p. 2656-68. 
31. Nunomura, A., et al., Oxidative damage is the earliest event in Alzheimer disease. J 
Neuropathol Exp Neurol, 2001. 60(8): p. 759-67. 
32. Pratico, D., et al., Increased lipid peroxidation precedes amyloid plaque formation in 
an animal model of Alzheimer amyloidosis. J Neurosci, 2001. 21(12): p. 4183-7. 
33. Stokin, G.B., et al., Axonopathy and transport deficits early in the pathogenesis of 
Alzheimer's disease. Science, 2005. 307(5713): p. 1282-8. 
34. Wang, X., et al., The role of abnormal mitochondrial dynamics in the pathogenesis of 
Alzheimer's disease. J Neurochem, 2009. 109 Suppl 1: p. 153-9. 
35. Calkins, M.J., et al., Impaired mitochondrial biogenesis, defective axonal transport of 
mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a 
mouse model of Alzheimer's disease. Hum Mol Genet, 2011. 20(23): p. 4515-29. 
36. Schapira, A.H., et al., Mitochondrial complex I deficiency in Parkinson's disease. 
Lancet, 1989. 1(8649): p. 1269. 
37. Chen, H. and D.C. Chan, Mitochondrial dynamics--fusion, fission, movement, and 
mitophagy--in neurodegenerative diseases. Hum Mol Genet, 2009. 18(R2): p. R169-
76. 
38. Kim, J., et al., Mitochondrial loss, dysfunction and altered dynamics in Huntington's 
disease. Hum Mol Genet, 2010. 19(20): p. 3919-35. 
39. Pandey, M., K.P. Mohanakumar, and R. Usha, Mitochondrial functional alterations in 
relation to pathophysiology of Huntington's disease. J Bioenerg Biomembr, 2010. 
42(3): p. 217-26. 
40. Choo, Y.S., et al., Mutant huntingtin directly increases susceptibility of mitochondria 
to the calcium-induced permeability transition and cytochrome c release. Hum Mol 
Genet, 2004. 13(14): p. 1407-20. 
41. Yano, H., et al., Inhibition of mitochondrial protein import by mutant huntingtin. Nat 
Neurosci, 2014. 17(6): p. 822-31. 
42. Gu, M., et al., Mitochondrial defect in Huntington's disease caudate nucleus. Ann 
Neurol, 1996. 39(3): p. 385-9. 
43. Shirendeb, U.P., et al., Mutant huntingtin's interaction with mitochondrial protein 
Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and 
synaptic degeneration in Huntington's disease. Hum Mol Genet, 2012. 21(2): p. 406-
20. 
65 
 
44. Brenner, S., The genetics of Caenorhabditis elegans. Genetics, 1974. 77(1): p. 71-94. 
45. Hekimi, S., et al., Molecular genetics of life span in C. elegans: how much does it 
teach us? Trends Genet, 1998. 14(1): p. 14-20. 
46. Lapierre, L.R. and M. Hansen, Lessons from C. elegans: signaling pathways for 
longevity. Trends Endocrinol Metab, 2012. 23(12): p. 637-44. 
47. Hobert, O., Specification of the nervous system. WormBook, 2005: p. 1-19. 
48. Hobert, O., Neurogenesis in the nematode Caenorhabditis elegans. WormBook, 2010: 
p. 1-24. 
49. Fay, D.S., The cell cycle and development: lessons from C. elegans. Semin Cell Dev 
Biol, 2005. 16(3): p. 397-406. 
50. Mallo, G.V., et al., Inducible antibacterial defense system in C. elegans. Curr Biol, 
2002. 12(14): p. 1209-14. 
51. Kurz, C.L. and J.J. Ewbank, Caenorhabditis elegans: an emerging genetic model for 
the study of innate immunity. Nat Rev Genet, 2003. 4(5): p. 380-90. 
52. Kaletta, T. and M.O. Hengartner, Finding function in novel targets: C. elegans as a 
model organism. Nat Rev Drug Discov, 2006. 5(5): p. 387-98. 
53. Giacomotto, J. and L. Segalat, High-throughput screening and small animal models, 
where are we? Br J Pharmacol, 2010. 160(2): p. 204-16. 
54. Lai, C.H., et al., Identification of novel human genes evolutionarily conserved in 
Caenorhabditis elegans by comparative proteomics. Genome Res, 2000. 10(5): p. 
703-13. 
55. Markaki, M. and N. Tavernarakis, Modeling human diseases in Caenorhabditis 
elegans. Biotechnol J, 2010. 5(12): p. 1261-76. 
56. Rieckher, M., et al., Transgenesis in Caenorhabditis elegans. Methods Mol Biol, 
2009. 561: p. 21-39. 
57. White, J.G., et al., The structure of the nervous system of the nematode 
Caenorhabditis elegans. Philos Trans R Soc Lond B Biol Sci, 1986. 314(1165): p. 1-
340. 
58. Ward, S., et al., Electron microscopical reconstruction of the anterior sensory 
anatomy of the nematode Caenorhabditis elegans.?2UU. J Comp Neurol, 1975. 
160(3): p. 313-37. 
59. Way, J.C. and M. Chalfie, The mec-3 gene of Caenorhabditis elegans requires its own 
product for maintained expression and is expressed in three neuronal cell types. 
Genes Dev, 1989. 3(12A): p. 1823-33. 
60. Chalfie, M., et al., Green fluorescent protein as a marker for gene expression. 
Science, 1994. 263(5148): p. 802-5. 
61. Peng, C.Y., et al., C. elegans model of neuronal aging. Commun Integr Biol, 2011. 
4(6): p. 696-8. 
62. Tank, E.M., K.E. Rodgers, and C. Kenyon, Spontaneous age-related neurite 
branching in Caenorhabditis elegans. J Neurosci, 2011. 31(25): p. 9279-88. 
63. Toth, M.L., et al., Neurite sprouting and synapse deterioration in the aging 
Caenorhabditis elegans nervous system. J Neurosci, 2012. 32(26): p. 8778-90. 
64. Yanik, M.F., et al., Neurosurgery: functional regeneration after laser axotomy. 
Nature, 2004. 432(7019): p. 822. 
65. Kage, E., et al., MBR-1, a novel helix-turn-helix transcription factor, is required for 
pruning excessive neurites in Caenorhabditis elegans. Curr Biol, 2005. 15(17): p. 
1554-9. 
66. Bargmann, C.I., Neurobiology of the Caenorhabditis elegans genome. Science, 1998. 
282(5396): p. 2028-33. 
66 
 
67. Sawin, E.R., R. Ranganathan, and H.R. Horvitz, C. elegans locomotory rate is 
modulated by the environment through a dopaminergic pathway and by experience 
through a serotonergic pathway. Neuron, 2000. 26(3): p. 619-31. 
68. Hobert, O., Behavioral plasticity in C. elegans: paradigms, circuits, genes. J 
Neurobiol, 2003. 54(1): p. 203-23. 
69. Smith, C.J., et al., Time-lapse imaging and cell-specific expression profiling reveal 
dynamic branching and molecular determinants of a multi-dendritic nociceptor in C. 
elegans. Dev Biol, 2010. 345(1): p. 18-33. 
70. Albeg, A., et al., C. elegans multi-dendritic sensory neurons: morphology and 
function. Mol Cell Neurosci, 2011. 46(1): p. 308-17. 
71. Smith, C.J., et al., Netrin (UNC-6) mediates dendritic self-avoidance. Nat Neurosci, 
2012. 15(5): p. 731-7. 
72. Liu, O.W. and K. Shen, The transmembrane LRR protein DMA-1 promotes dendrite 
branching and growth in C. elegans. Nat Neurosci, 2012. 15(1): p. 57-63. 
73. Dong, X., et al., An extracellular adhesion molecule complex patterns dendritic 
branching and morphogenesis. Cell, 2013. 155(2): p. 296-307. 
74. Wolozin, B., et al., Watching worms whither: modeling neurodegeneration in C. 
elegans. Prog Mol Biol Transl Sci, 2011. 100: p. 499-514. 
75. Li, J. and W. Le, Modeling neurodegenerative diseases in Caenorhabditis elegans. 
Exp Neurol, 2013. 250: p. 94-103. 
76. Johnson, J.R., et al., Caenorhabditis elegans: a useful tool to decipher 
neurodegenerative pathways. Biochem Soc Trans, 2010. 38(2): p. 559-63. 
77. Dosanjh, L.E., et al., Behavioral phenotyping of a transgenic Caenorhabditis elegans 
expressing neuronal amyloid-beta. J Alzheimers Dis, 2010. 19(2): p. 681-90. 
78. Wentzell, J. and D. Kretzschmar, Alzheimer's disease and tauopathy studies in flies 
and worms. Neurobiol Dis, 2010. 40(1): p. 21-8. 
79. Wiese, M., A. Antebi, and H. Zheng, Intracellular trafficking and synaptic function of 
APL-1 in Caenorhabditis elegans. PLoS One, 2010. 5(9). 
80. Lakso, M., et al., Dopaminergic neuronal loss and motor deficits in Caenorhabditis 
elegans overexpressing human alpha-synuclein. J Neurochem, 2003. 86(1): p. 165-72. 
81. Dauer, W. and C.C. Ho, The biology and pathology of the familial Parkinson's disease 
protein LRRK2. Mov Disord, 2010. 25 Suppl 1: p. S40-3. 
82. Saha, S., et al., LRRK2 modulates vulnerability to mitochondrial dysfunction in 
Caenorhabditis elegans. J Neurosci, 2009. 29(29): p. 9210-8. 
83. Faber, P.W., et al., Polyglutamine-mediated dysfunction and apoptotic death of a 
Caenorhabditis elegans sensory neuron. Proc Natl Acad Sci U S A, 1999. 96(1): p. 
179-84. 
84. Parker, J.A., et al., Expanded polyglutamines in Caenorhabditis elegans cause axonal 
abnormalities and severe dysfunction of PLM mechanosensory neurons without cell 
death. Proc Natl Acad Sci U S A, 2001. 98(23): p. 13318-23. 
85. Sin, O., H. Michels, and E.A. Nollen, Genetic screens in Caenorhabditis elegans 
models for neurodegenerative diseases. Biochim Biophys Acta, 2014. 1842(10): p. 
1951-1959. 
86. Ventura, N. and S.L. Rea, Caenorhabditis elegans mitochondrial mutants as an 
investigative tool to study human neurodegenerative diseases associated with 
mitochondrial dysfunction. Biotechnol J, 2007. 2(5): p. 584-95. 
87. Tsalik, E.L., et al., LIM homeobox gene-dependent expression of biogenic amine 
receptors in restricted regions of the C. elegans nervous system. Dev Biol, 2003. 
263(1): p. 81-102. 
67 
 
88. Kayser, E.B., P.G. Morgan, and M.M. Sedensky, GAS-1: a mitochondrial protein 
controls sensitivity to volatile anesthetics in the nematode Caenorhabditis elegans. 
Anesthesiology, 1999. 90(2): p. 545-54. 
89. Kayser, E.B., et al., Mitochondrial expression and function of GAS-1 in 
Caenorhabditis elegans. J Biol Chem, 2001. 276(23): p. 20551-8. 
90. Yang, W. and S. Hekimi, Two modes of mitochondrial dysfunction lead independently 
to lifespan extension in Caenorhabditis elegans. Aging Cell, 2010. 9(3): p. 433-47. 
91. Yang, W. and S. Hekimi, A mitochondrial superoxide signal triggers increased 
longevity in Caenorhabditis elegans. PLoS Biol, 2010. 8(12): p. e1000556. 
92. Hekimi, S., J. Lapointe, and Y. Wen, Taking a "good" look at free radicals in the 
aging process. Trends Cell Biol, 2011. 21(10): p. 569-76. 
93. Padayatty, S.J., et al., Vitamin C as an antioxidant: evaluation of its role in disease 
prevention. J Am Coll Nutr, 2003. 22(1): p. 18-35. 
94. Clark, S.G. and C. Chiu, C. elegans ZAG-1, a Zn-finger-homeodomain protein, 
regulates axonal development and neuronal differentiation. Development, 2003. 
130(16): p. 3781-94. 
95. Viscomi, C., et al., In vivo correction of COX deficiency by activation of the 
AMPK/PGC-1alpha axis. Cell Metab, 2011. 14(1): p. 80-90. 
96. Li, L., Y. Chen, and S.B. Gibson, Starvation-induced autophagy is regulated by 
mitochondrial reactive oxygen species leading to AMPK activation. Cell Signal, 2013. 
25(1): p. 50-65. 
97. Hardie, D.G., AMP-activated protein kinase: an energy sensor that regulates all 
aspects of cell function. Genes Dev, 2011. 25(18): p. 1895-908. 
98. Apfeld, J., et al., The AMP-activated protein kinase AAK-2 links energy levels and 
insulin-like signals to lifespan in C. elegans. Genes Dev, 2004. 18(24): p. 3004-9. 
99. Curtis, R., G. O'Connor, and P.S. DiStefano, Aging networks in Caenorhabditis 
elegans: AMP-activated protein kinase (aak-2) links multiple aging and metabolism 
pathways. Aging Cell, 2006. 5(2): p. 119-26. 
100. Golubitzky, A., et al., Screening for active small molecules in mitochondrial complex I 
deficient patient's fibroblasts, reveals AICAR as the most beneficial compound. PLoS 
One, 2011. 6(10): p. e26883. 
101. Shi, S.H., L.Y. Jan, and Y.N. Jan, Hippocampal neuronal polarity specified by 
spatially localized mPar3/mPar6 and PI 3-kinase activity. Cell, 2003. 112(1): p. 63-
75. 
102. Menager, C., et al., PIP3 is involved in neuronal polarization and axon formation. J 
Neurochem, 2004. 89(1): p. 109-18. 
103. Amato, S., et al., AMP-activated protein kinase regulates neuronal polarization by 
interfering with PI 3-kinase localization. Science, 2011. 332(6026): p. 247-51. 
104. Morris, J.Z., H.A. Tissenbaum, and G. Ruvkun, A phosphatidylinositol-3-OH kinase 
family member regulating longevity and diapause in Caenorhabditis elegans. Nature, 
1996. 382(6591): p. 536-9. 
105. Kenyon, C., et al., A C. elegans mutant that lives twice as long as wild type. Nature, 
1993. 366(6454): p. 461-4. 
106. Chaturvedi, R.K. and M. Flint Beal, Mitochondrial diseases of the brain. Free Radic 
Biol Med, 2013. 63: p. 1-29. 
107. Dasgupta, B. and J. Milbrandt, AMP-activated protein kinase phosphorylates 
retinoblastoma protein to control mammalian brain development. Dev Cell, 2009. 
16(2): p. 256-70. 
108. Williams, T., et al., AMP-activated protein kinase (AMPK) activity is not required for 
neuronal development but regulates axogenesis during metabolic stress. Proc Natl 
Acad Sci U S A, 2011. 108(14): p. 5849-54. 
68 
 
109. Hardie, D.G., et al., Management of cellular energy by the AMP-activated protein 
kinase system. FEBS Lett, 2003. 546(1): p. 113-20. 
110. Wu, Z., et al., Mechanisms controlling mitochondrial biogenesis and respiration 
through the thermogenic coactivator PGC-1. Cell, 1999. 98(1): p. 115-24. 
111. Lehman, J.J., et al., Peroxisome proliferator-activated receptor gamma coactivator-1 
promotes cardiac mitochondrial biogenesis. J Clin Invest, 2000. 106(7): p. 847-56. 
112. Puigserver, P. and B.M. Spiegelman, Peroxisome proliferator-activated receptor-
gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic 
regulator. Endocr Rev, 2003. 24(1): p. 78-90. 
113. Lee, W.J., et al., AMPK activation increases fatty acid oxidation in skeletal muscle by 
activating PPARalpha and PGC-1. Biochem Biophys Res Commun, 2006. 340(1): p. 
291-5. 
114. Yu, L. and S.J. Yang, AMP-activated protein kinase mediates activity-dependent 
regulation of peroxisome proliferator-activated receptor gamma coactivator-1alpha 
and nuclear respiratory factor 1 expression in rat visual cortical neurons. 
Neuroscience, 2010. 169(1): p. 23-38. 
115. Ashabi, G., et al., Activation of AMP-activated protein kinase by metformin protects 
against global cerebral ischemia in male rats: interference of AMPK/PGC-1alpha 
pathway. Metab Brain Dis, 2014. 29(1): p. 47-58. 
116. Knutti, D., A. Kaul, and A. Kralli, A tissue-specific coactivator of steroid receptors, 
identified in a functional genetic screen. Mol Cell Biol, 2000. 20(7): p. 2411-22. 
117. Taubert, S., et al., A Mediator subunit, MDT-15, integrates regulation of fatty acid 
metabolism by NHR-49-dependent and -independent pathways in C. elegans. Genes 
Dev, 2006. 20(9): p. 1137-49. 
118. Cheng, A., et al., Involvement of PGC-1alpha in the formation and maintenance of 
neuronal dendritic spines. Nat Commun, 2012. 3: p. 1250. 
119. Shirwany, N.A. and M.H. Zou, AMPK: a cellular metabolic and redox sensor. A 
minireview. Front Biosci (Landmark Ed), 2014. 19: p. 447-74. 
120. Zsurka, G. and W.S. Kunz, Mitochondrial involvement in neurodegenerative diseases. 
IUBMB Life, 2013. 65(3): p. 263-72. 
121. Cavallucci, V., A. Nobili, and M. D'Amelio, Emerging role of mitochondria 
dysfunction in the onset of neurodegenerative diseases. J Biol Regul Homeost Agents, 
2013. 27(2 Suppl): p. 1-9. 
122. Yun, H. and J. Ha, AMP-activated protein kinase modulators: a patent review (2006 - 
2010). Expert Opin Ther Pat, 2011. 21(7): p. 983-1005. 
123. Spasic, M.R., P. Callaerts, and K.K. Norga, AMP-activated protein kinase (AMPK) 
molecular crossroad for metabolic control and survival of neurons. Neuroscientist, 
2009. 15(4): p. 309-16. 
124. Godoy, J.A., et al., Signaling pathway cross talk in Alzheimer's disease. Cell Commun 
Signal, 2014. 12: p. 23. 
125. Rolland, S.G., et al., Impaired complex IV activity in response to loss of LRPPRC 
function can be compensated by mitochondrial hyperfusion. Proc Natl Acad Sci U S 
A, 2013. 110(32): p. E2967-76. 
126. Spillane, M., et al., Mitochondria coordinate sites of axon branching through 
localized intra-axonal protein synthesis. Cell Rep, 2013. 5(6): p. 1564-75. 
127. Coburn, C.M. and C.I. Bargmann, A putative cyclic nucleotide-gated channel is 
required for sensory development and function in C. elegans. Neuron, 1996. 17(4): p. 
695-706. 
128. Coburn, C.M., et al., A cyclic nucleotide-gated channel inhibits sensory axon 
outgrowth in larval and adult Caenorhabditis elegans: a distinct pathway for 
maintenance of sensory axon structure. Development, 1998. 125(2): p. 249-58. 
69 
 
129. Kaupp, U.B. and R. Seifert, Cyclic nucleotide-gated ion channels. Physiol Rev, 2002. 
82(3): p. 769-824. 
130. Dell'agnello, C., et al., Increased longevity and refractoriness to Ca(2+)-dependent 
neurodegeneration in Surf1 knockout mice. Hum Mol Genet, 2007. 16(4): p. 431-44. 
131. Husson, S.J., et al., Optogenetic analysis of a nociceptor neuron and network reveals 
ion channels acting downstream of primary sensors. Curr Biol, 2012. 22(9): p. 743-
52. 
132. Schmitt, C., et al., Specific expression of channelrhodopsin-2 in single neurons of 
Caenorhabditis elegans. PLoS One, 2012. 7(8): p. e43164. 
133. Flood, D.G., et al., Age-related dendritic growth in dentate gyrus of human brain is 
followed by regression in the 'oldest old'. Brain Res, 1985. 345(2): p. 366-8. 
134. Flood, D.G., et al., Dendritic extent in human dentate gyrus granule cells in normal 
aging and senile dementia. Brain Res, 1987. 402(2): p. 205-16. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
70 
 
8. Acknowledgement 
Part of this work was funded by the CoEN initiative. I would like to thank my supervisor Dr. 
Daniele Bano for the encouragement to push me through this process successfully and the 
trust he showed in my work. Additionally I would like to thank, Professors Nicotera and, 
Hoch for agreeing to supervise me, and Professors Pankratz and Stoecker for agreeing to 
participate in my PhD examination. 
I am grateful to all the former and current members of the Bano and Nicotera groups which 
have been great supporters and collaborators and gave me precious scientific and personal 
feedback in several occasions. Without them creating a relaxing atmosphere in the laboratory, 
my work would have been much different. 
In addition, I would like to thank Mrs. Steffi Nicolaus from the media kitchen of DZNE for 
the incredible competence she shows daily in supporting us with her technical assistance. 
Furthermore, Dr. Ireen Koenig of the DZNE Light Microscopy Facility has been a great 
teacher in the use of confocal microscopy for the needs of this study. Along with these people 
I would like to thank all the staff of the DZNE Light Microscopy Facility, Technical 
Infrastructure and the Information Technology for their precious help whenever I needed it. 
Mrs. Regina Otto and Mrs. Fabienne Fier have also offered their assistance as former and 
current, respectively, secretaries of our group. 
Last but not least, I would like to thank my family and friends who, although several miles 
away, have been my greatest funs and faithful supporters. I owe them a lot. 
 
 
 
 
 
 
 
 
 
 
 
 
 
